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Section I
Valley Fever: Educating Primary Care
Providers and Allied Healthcare Professionals
Abstract
Problem: Coccidioidomycosis (cocci), informally Valley Fever (VF), infects the lungs with the
fungal spore coccidioides. It is prevalent in areas where soil disturbance occurs. Currently, there
are no related educational or standardized guidelines exist for primary care providers (PCPs) in
California’s Central Valley, where VF is highly endemic (Centers for Disease Control and
Prevention, 2018).
Context: A Doctor of Nursing Practice project educational program for PCPs and allied
healthcare workers (AHWs) at the Adventist Health Central Valley Network (AHCVN) clinics.
The project aimed to educate PCPs to recognize, test, diagnose, and treat high-risk patients of VF
expeditiously.
Interventions: A virtual presentation for PCPs and AHWs on the history, symptoms, risk
factors, preventative measures, and a treatment algorithm for VF.
Measures: Pre/post surveys determined changes in knowledge and confidence levels. Common
clinical scenarios informed courses of recommenced treatments.
Results: Forty participants attended the session. Results indicated increased knowledge by
12.63%.
Conclusions: PCPs have scant knowledge on VF, resulting in increased patient morbidity and
expenditures. The VF program was of particular interest for this group of providers based on the
geographical location and a vulnerable population. AHCVN included four clinics in rural Fresno
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County. Screening, diagnosing, and treating VF improved following the educational program
based on the post knowledge survey scores of 12.63%.

Keywords: algorithm, coccidioidomycosis, dust exposure, risk factors, valley fever
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Section II: Introduction
Background of Valley Fever
The San Joaquin Valley in Central California is a semiarid region that is known to be
highly endemic for coccidioidomycosis infections in high-risk groups. Coccidioidomycosis
(cocci), also known as Valley Fever (VF), is caused by the fungal spore coccidioides, which can
be found in the soil of arid and semiarid regions in the Southwest United States and parts of
Central and South America. California’s Central Valley is considered highly endemic because of
its temperate climate (11.7-27.9 degrees Celsius) and silt-like soil (Ampel, 2009). Disturbing soil
through excavation, agricultural activities, or other soil movement can release fungal spores into
the air and people who are in close proximity can inhale them. Transmission via the respiratory
tract can cause a cocci infection (CI) of the lungs that mimic flu-like symptoms, making for
frequent false diagnoses of this common respiratory illness. VF is noncommunicable and is
spread only by dust storms and wind; it can affect both people and animals.
In the United States, the Centers for Disease Control and Prevention (CDC, 2018)
reported over 10,000 VF cases in 2017 and, according to the California Department of Public
Health (CDPH, 2019), California, alone, reported approximately 8,187 cases. Symptoms of VF,
such as fever, cough, chest congestion, joint pain, fatigue, shortness of breath, pleuritic pain, and
rashes to the lower extremities, can occur one to three weeks after exposure, but not necessarily
concurrently (Cooksey et al., 2017). Individuals most affected are farm and ranch workers,
construction workers, military personnel, archeologists, geologists, firefighters, persons with
compromised immune systems or diabetics, and pregnant women (Johnson et al., 2014). In
addition, people of color are at higher risk, specifically African Americans, Filipinos, Native
Americans, Hispanics, and Asians (Johnson et al., 2014).
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Problem Description
Current literature indicates a lack of education and knowledge on the prevention,
diagnosis, and treatment of VF among primary care providers (PCPs) (Benedict et al., 2018).
Presently, no vaccine exists to protect at-risk individuals; however, research toward that end is
ongoing.
With each day of misdiagnosis, VF can migrate into other areas of the body, such as the
skin, bones, and major organs (Towle, 2014), with the prognosis becoming life-threatening and
debilitating for years. The diagnosis of cocci is made through serology testing and a chest
radiograph, but prior to any testing, the PCP must evaluate the individual’s occupational and
travel history, clinical symptoms, contributing ethnicity, and co-morbidities. The populations at
highest risk for CIs are workers who engage in soil disturbing occupations, communities in high
dust areas, persons of specific ethnicities, and persons with certain co-morbidities. These
vulnerable groups are neither screened nor tested efficiently due to insufficient education among
PCPs. On average, most patients receive an accurate diagnosis after four weeks of first visiting a
doctor (Benedict at al., 2018; Wilson et al., 2019).
Available Knowledge
The PICOT question for the DNP project was in (P) high-risk populations of 18 years and
older, (I) how an educational session on VF did, (C) compared to no educational session (O)
impacted the provider’s knowledge. The Johns Hopkins Research Evidence Appraisal Tools
(Dearholt & Dang, 2017) were used to analyze the chosen studies to evaluate the gap in
knowledge in current primary clinical practices on VF.
Current research indicates a dearth of education and knowledge on the prevention,
disease pathology, and early detection of cocci. This neglected disease, with a specific geography
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for this at-risk population, has led to researched recommendations to change health care practices
for VF in Central California. The following is a synthesis of evidence to achieve the goal in
improving screening, diagnosing and treating VF through public awareness and provider
education.
Literature Review
Search Process
A review of evidence was completed by searching PubMed, Scopus, and the Cumulative
Index to Nursing and Allied Health Literature (CINAHL) databases with keywords words, such
as “coccidioidomycosis,” “prevention,” “screening program,” and “Central Valley” to locate the
appropriate articles. Exclusion criteria included animal studies and studies published in
languages other than English. Inclusion criteria included articles that were peer reviewed, human
subjects only, occupational groups, and publication within five years to maintain current
evidence. The search process yielded 20 articles on cocci and other fungal diseases. The
following articles were chosen because they answered the PICOT question and its contributing
factors. The evidence presented is consistent with geographical, gender, occupational, and
vulnerability risks for a CI. The search process produced only 10 current articles within a fiveyear period. There were articles on cocci and/or VF that were extrapolated in the search process,
but they were either irrelevant to the PICOT question or older than the five-year minimum. In
addition, although only U.S. studies were reviewed, studies involving different clinical
situations, and similar studies done by different researchers in the identical geographical
locations with the similar populations produced equivalent results and pathogenesis of the
disease further verified the findings of this evaluation.
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Evaluation of Evidence
Valley Fever Prevention
Johnson et al. (2014) reviewed the pathophysiology of cocci, its geographic distribution
of the fungal spores, vulnerable populations (including health status, age, and ethnicity), and
occupations at risk for cocci infection. The authors further discussed the appropriate use of
diagnostics and treatments, but the strongest recommendations were on prevention through
awareness and early detection.
Delays in Detection in Non-endemic States
A surveillance study conducted by Benedict et al. (2018) from January 1 through
December 31, 2016 compared 14 states (Louisiana, Michigan, Minnesota, Missouri, Montana,
Nevada, New Mexico, North Dakota, Ohio, Oregon, Pennsylvania, Utah, Wisconsin, and
Wyoming) to Arizona and California, both known to be highly endemic for cocci. This quasiexperimental study compared CIs in California and Arizona to the 14 nonendemic and lowendemic states listed above. It concluded that 29% of patients from nonendemic and lowendemic states who had traveled to highly cocci-endemic regions had more disease occurrences
and were serologically positive for cocci. Benedict et al. (2018) reported that a CI can cause
severe respiratory illness and that “improved coccidioidomycosis awareness in non-highly
endemic areas is needed” (p. 1444). Additionally, this study summated that there were delays in
diagnosis, unnecessary antibacterial use, and prolonged symptoms were common in lower cocciawareness states than in highly endemic states.
Recommendation for Education on Valley Fever
Tartof et al.’s (2018) cohort study on community-acquired pneumonia (CAP) patients in
Southern California who were delayed in their diagnoses of VF resulting in multiple courses of
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antibiotics, more inpatient hospitalizations, and more chest radiographs due to repeated
admissions for CAP. Illustrated in their report, a geographical map showed that Kern County had
a higher incidence rate for cocci than did Los Angeles County. The study found a low testing rate
in CAP with cocci; therefore, the researchers recommended additional VF education for
physicians and the community to address overall detection, treatment, and expenditures. Total
healthcare direct expenditures included the initial diagnosis, follow-up physician’s visits,
treatment procedures, medications, hospitalizations, and home care or nursing home costs
(Wilson et al., 2019). The study in California included 7,466 patients with confirmed cocci in
2017. The total lifetime direct and indirect healthcare cost burden for cocci in California in 2017
was $700 million, with $429 million in direct costs and $271 million in indirect costs (Wilson et
al., 2019). Per person direct costs were highest in disseminated disease of $1,023,730. For
uncomplicated cocci with pneumonia, the cost burden per person was $22,039, not including the
indirect costs incurred by employers from morbidity disability and mortality payments and lost
days of work. Wilson et al. (2019) supports the available knowledge to endorse policy
development, resource justification, funding, and management of public health.
Risk of Valley Fever from Occupational Exposure
A quasi-experimental study by Cooksey et al. (2017) at two solar construction farms in
San Luis Obispo County, California concluded that exposure to dust during soil disturbing
activities, such as excavating and digging in trenches without a respirator and having been
exposed to a dust storm, showed clinical significance for confirmed symptomatic cocci. Frequent
wetting of soil was found to be a protective factor before soil-disturbance. This study compared
89 solar farm workers with confirmed clinical cocci to 325 asymptomatic workers who
frequently worked in dust clouds or storms. The statistical analysis revealed that over 80% of
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workers with confirmed clinical cocci reported symptoms of cough, difficulty breathing, fatigue,
night sweats, fever, muscle and/or joint pain, weakness, and headaches. Cooksey et al. (2017)
discussed the use of environmental safety measures to control dust exposure in construction,
such as wearing a mask, changing clothing and/or showering before going home, wetting down
soil before excavation or trenching, enclosed cabs with closed windows on earth movers, and the
suspension of soil disturbing activities during windstorms. This study provided strong evidence
on dust exposure and rate of infection by the coccoidal spores in endemic regions for VF. To
further support the evidence of dust exposure as a risk factor for cocci, an article in The Fresno
Bee stated that 2017 was a bad year in California for coccidioides: 7,466 infection cases, for a
rate of 18.8 per 100,000 persons (Anderson, 2018). Anderson also confirmed that prolonged dry,
hot weather and dust storms could have increased VF, where airborne fungal spores were
inhaled.
Immunology on Valley Fever
Kirkland (2016) reviewed immunology, microbiology, and vaccination trials to help
promote the development of a vaccine against coccidioides. Kirkland (2016) reported that once
infection occurs by the fungal spores, a second infection is unlikely; therefore, an initial antibody
response to the CI is a protective factor and that vaccination seemed biologically possible.
Immunization against cocci is attainable and sensible because while most cases resolve
spontaneously without severe symptoms, 40% of infections are severe enough to require
antifungal medications (Kirkland, 2016). This was only a review article by Kirkland’s (2016)
reporting a study that was conducted in the 1980’s by researchers who executed a human trial of
a cocci vaccine, using killed whole spherule immunization. This was double-blind human study
that compared the vaccine to a placebo and used clinical outcomes as an endpoint. Of the 3,000
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people vaccinated in the study, only a minority became skin-test positive. Kirkland (2016)
reported that the study found no difference in the number of cases of cocci in the vaccinated
group versus the placebo group. The study concluded that further vaccine studies were needed.
Dust Exposure to Heavy Equipment Workers
A review article by de Perio et al. (2019) included four occupational cocci outbreaks
from 2007–2014 in California. The surveillance data represented construction workers at
numerous excavation sites and cast and crew workers at an outdoor filming site. The objectives
were to collect data on workers who presented with clinical cocci in San Luis Obispo County
during 2007 and 2011-2014, Kern County in 2008, and Ventura County in 2012. The survey
assessed the burden of illness from cocci and identified industries and occupations for high risk
for CI, such as agriculture, construction, archelogy, mining, military maneuvers, and oil and gas
extraction (de Perio et al., 2019). In San Luis Obispo County in 2007, one out of twelve
construction crew workers developed respiratory symptoms conclusive of acute pulmonary cocci
while excavating a leaking underground pipe; their illness onset was less than one month after
beginning work. The sandy soil consistency lessened the effectiveness of soil wetting, heavy
equipment was used for trenching with windows open, and none of the workers wore masks.
Kern County, 2008, had eight out of ten construction workers develop CI in less than one
month while widening a box culvert. During the construction, none of the workers were advised
to use masks, heavy equipment was operated with open windows, and water was used
infrequently for dust suppression. Furthermore, the contractor was not informed of cocciassociated risk factors in endemic areas.
In 2012, Ventura County had a filming crew work outdoors with soil disturbance
activities, such as grading, digging, and traveling on dirt roads, causing dust clouds. In less than
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one month after exposure, 10 out of 655 workers had clinical cocci symptoms, with five of the
ten symptomatic individuals having serology-confirmed disease. The casting agency did not
provide the crew with personal protection and the employees received no information on the
risks of CI.
In San Luis Obispo County during 2011-2014, an outbreak of CI at two solar farms was
detected via data collection during December 2012 - February 2013. Of the 3,572 construction
workers at two neighboring solar farms, 44 workers tested positive for cocci with laboratory
confirmation. In addition, 89 workers with clinical CI were confirmed based on a mail-in survey
with no laboratory confirmation. Illness onset for all cases occurred within one week or more
after beginning work and less than one month after the last workday. Exposure at the solar farms
included digging, trenching, employees working in a dust cloud or dust storm, and operating
heavy equipment without enclosed cabs or without a high-efficiency HEPA filter (de Perio et al.,
2019).
Increase in Prevalence of Valley Fever based on Ethnicity and Geography
From 1990 to 2008, Noble et al. (2016) conducted a comparative study in cocciassociated deaths by geography, sex, and race/ethnicity in Arizona and California, versus the
United States. Nobel et al. (2016) used death certificates to identify independent demographic
variables, such as older age, male gender, and non-white race (in particular, African-American).
For Hispanic, Native American, and Asian populations, the risks were lower when compared to
non-Hispanic Whites. The statistics showed, comparatively, that highly endemic states, like
California and Arizona, had higher mortality rates than the national average. . In the data
collected by Nobel et al. (2016) on a total of 3,088 cocci-related deaths in Arizona and
California, men were affected more than were women. On a national scale, men had a higher
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mortality rate than did women, 0.93 per one million and 0.31 per million, respectively.
Comparing just Arizona and California, the total cocci-related mortality rates were between
1.95– 2.54 per million for Arizona, and 2.68–3.60 per million for California compared to the
U.S. mortality rate of 2.80-3.27 per million . In addition, Ampel (2009) explained that climate
impacted prevalence and incidence of cocci. He reported that the Palmer drought severity index,
wind velocity, temperature, and cumulative rainfall significantly increased the risk of cocci.
Healthcare Expenditures on Valley Fever
Studies have shown that a delay in diagnosis potentially increases recovery time and
expenditure dollars. Wilson et al.’s (2019) cost-of-illness study examined the direct and indirect
costs of VF by reviewing current literature, national datasets from the Federal Reserve and from
the California patient discharge dataset 2017, ICD-10 codes for cocci, and expert interviews on
the natural course of VF and its treatment algorithms. The lifetime cost-burden of VF cases
reported in 2017 in California was just under $700 million, with $429 million in direct costs
(diagnosis work-up, treatment, medications, procedures, hospitalizations, home and nursing
home care costs, and follow-up) and $271 million in indirect costs (loss of productivity from
work, short and long-term disability, and mortality estimates). The study population was 7,466
patients from the 2017 VF cases in California. Guided interviews were conducted with VF
experts on the natural history of CI and published treatment guidelines.
Clinical Practice Guidelines for the Treatment of Valley Fever
This clinical review by Galgiani et al. (2016) studied the Infectious Diseases Society of
America (IDSA) guidelines for clinical situations affected by cocci and used common clinical
syndromes (complicated and uncomplicated) and specific demographics. The panel of
researchers systematically weighed the strength of the recommended therapy and the Grading of
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Recommendations Assessment, Development and Evaluation (GRADE) system for the quality of
evidence. This clinical review also used the IDSA practice guidelines to outline the current
diagnostic and treatment methods for specific clinical circumstances of cocci.
The Effects of Dust Exposure on Outdoor Agricultural Workers
The final article summarized and verified the connection between adult Hispanic outdoor
agricultural workers in California and dust exposure from harvesting crops. McCurdy et al.
(2020) conducted a case control study of workers seen at the Kern County medical facility who
were referred to the public health laboratory for cocci serologic testing from June 1, 2016
through August 31, 2018. Of the 203, 18+ year-old participants, 110 were positive for cocci
serology and 93 were negative (controls). Persons with positive cocci serologies reported weight
loss, shortness of breath, fatigue, weakness, and cough. Over 50% of the participants were
women and more than 75% were born in Mexico; each completed an interviewer-administered
health and work questionnaire. The study found that CIs among the farm workers were higher for
those who worked with root and bulb vegetable crops (beets, carrots, potatoes, radishes, and
onions), which grow underground, than with near or above-ground crops. A protective factor was
leaf crops (blueberries, chili peppers, cotton, grapes, lettuce, strawberries, and spinach), which
were near-ground, and tree crops (almonds, apples, apricots, cherries, kiwis, oranges,
pomegranates and pistachios), which grow above ground. Additionally, mask use and soil
wetting showed modest and statistically insignificant protective effects from dust exposure. The
study concluded that dust exposure secondary to work with root and bulb vegetable crops was
associated with increased risk for cocci among Hispanic farm workers.
The literature review revealed an overall focus on prevention, early diagnosis, and
rigorous treatment of CIs. The need to educate both PCPs and employers about VF and its
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contributing factors in high-risk populations is plain. The literature review answered the PICOT
question, provided studies on adults 18+ years of age, and showed that the contributing factors
for misdiagnosis of VF and neglect of precautions for VF were lack of provider education and
public awareness. For the purpose of this DNP project, efforts focused on educating only the
PCPs and AHWs. The literature review adequately answered the PICOT question with the
evidence from 10 researched articles, with the consistent factors being dust exposure to
vulnerable populations and early diagnosis and management (Appendix A).
Rationale
This clinical practice improvement project on VF addressed the need for CI awareness
and education for PCPs and AHWs in order to diagnose and treat patients earlier in the disease
process. The implementation of this project will potentially reduce the length of illness morbidity
and healthcare expenditures. The four AHCVN clinics with providers in the educational program
were located in Selma, Reedley, Hanford, and Tulare, California.
Conceptual Framework
The goal of Healthy People 2020 was to collaboratively involve three authoritative
bodies: (a) the United States Department of Health and Human Services (USDHHS), (b) public
stakeholders, and (c) health care advisory committees to improve nationwide healthcare and
wellness. Its mission has been to educate populations on health, disease, and disability and to
provide measurable health outcomes on community, state, and national levels. Policy
improvement for stakeholders and employers has been intended to procure health equality by
eliminating disparities and improve the social and physical environments of communities
(USDHHS, 2018a).
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A theoretical framework provided the blueprint for goal setting and predicting outcomes
of the implementation. The Conceptual Model of Nursing and Population Health (CMNPH) was
the nursing framework chosen to develop a community’s health improvement plan on VF via
provider education. Fawcett and Ellenbecker (2015) reported that the CMNPH is a global
perspective model of nursing in addressing a population’s health problem. Instead of using an
individualized model to address disease conditions, it is better to study at the population-level,
which also allows for better monitoring of expenditures. Currently, the United States government
budgets approximately 75% of its healthcare resources to curing diseases instead of preventing
them—with generally poor outcomes (Fawcett & Ellenbecker, 2015). Some of the health
indicators are infant mortality, injuries, homicides, adolescent pregnancies, sexually transmitted
diseases, drug-related deaths, obesity, diabetes, heart disease, chronic lung diseases, and
disabilities. When compared to countries with similar socioeconomic levels, the United States
performed poorly due to inadequate access to and affordability of healthcare, unhealthy
behaviors, adverse economic and social conditions, environmental factors, and public policies
and social values (Fawcett & Ellenbecker, 2015).
Closer examination of the current healthcare system reveals clear areas of need at the
population level involving epidemiology, geography, and community health. VF is common in
the Central Valley among high-risk and ethnic groups who work on farms, at construction sites,
and who live near these high dust areas. An educational plan on VF, guided by the CMNPH,
allowed the project manager (DNP author) to establish clear goals and objectives, while creating
an algorithm to test, diagnose, and treat VF early and efficiently. This education plan can be
replicated and can address the same health concerns in other populations with the same disease
risk factors and geography.
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The CMNPH, written by Fawcett and Ellenbecker (2015), promotes advocacy and policy
development on public health concerns for a defined population in a specific geographical range.
This conceptual model encompasses four determinants of population health:
1. Upstream factors, such as socioeconomic and physical environment.
2. Population factors, such as genetics, behavior, physiological issues, resilience, and
health state within a defined geographical area.
3. Health care system factors, such as providers, organizations and institutions, payers,
and policies.
4. Nursing activities, such as health promotion and wellness, restoration, maintenance,
and disease prevention.
This model aims to decrease disease burden, increase functional status, maintain life
expectancy, decrease morbidity and mortality, and improve the quality of life in high-risk
populations who work and live near soil disturbing activities and occupations (Fawcett &
Ellenbecker, 2015). The nursing activity accounts for upstream, population, and health care
system factors to guide the implementation of educating PCPs about VF (Appendix B). The
nursing activity implemented was directed for prevention and early detection of VF.
Purpose of the Project
Examination of the evidence on VF revealed an absence of educational programs or
standardized guidelines for PCPs who serve populations working in industries that cause soil
disturbance. Until recently, no mandated policies or guidelines existed, only recommendations
from the California division of Occupational Safety and Health (Cal OSHA) for occupational
exposure risks. On October 10, 2019, the Governor of California approved Assembly Bill (AB)
203 that went into effect on May 1, 2020 calling for all employers in construction in highly
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endemic areas to educate their employees on VF prevention. AB 203 applies to the following
counties: Fresno, Kern, Kings, Madera, Merced, Monterey, San Joaquin, San Luis Obispo, Santa
Barbara, Tulare, and Ventura (AB 203: Occupational Safety and Health, Chapter 712, 2019).
With the initiation of AB 203 (2019), at-risk communities will have improved outcomes
by integrating treatment and prevention. This approach, known as clinical population medicine
(CPM), will improve patient experience and curtail health care expenditures (Orkin et al., 2017)
by the implementation of a comprehensive educational program on VF for the providers at
AHCVN. The integration of CPM plans allows planners and policy makers to deliver effective
care that abates health disparities, fosters education, and reduces occupational risk exposures.
Orkin et al. (2017) affirmed that CPM will use patient and population data to deliver appropriate
clinical decisions and a healthcare system that can serve the needs of its community.
The use of epidemiological and medical evidence are practical means to improve public
health and clinical care for vulnerable populations. In addition, CPM will commission healthcare
institutions to reduce health disparities through improved access to health services, health
promotion, and disease prevention (Orkin et al., 2017). Epidemiological data, the literature
review, and the conceptual framework guided the implementation of the educational program for
improved screening and treatment of cocci. This conceptualization has supported and propelled
the VF education project for PCPs in order to ameliorate the health risks of a vulnerable
population in the Central Valley.
AIM Statement
Effective August 2020, this project developed, implemented, and evaluated a VF
educational program for PCPs in the Central Valley. The objectives included increasing PCP
knowledge of VF with regard to its prevalence, pathology, current treatments, and testing, and

VALLEY FEVER: EDUCATING PROVIDERS

20

increasing the percentage of early screenings in high-risk groups 18+ years of age for all genders.
This project’s goals for a specific population in a defined geographical region were measurable,
applicable, realistic, and timely.
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Section III: Methods
Context
This evidence-based change of practice project proposed to reduce morbidity and early
mortality among high-risk groups with clinical symptoms of CI through an education-based
training session for PCPs. The target population was PCPs at AHCVN who cared for patients
with clinically symptomatic CIs representing the following categories: (a) work or live in high
dust areas with soil disturbing activities, (b) immunocompromised individ uals, (c) people with
diabetes, (d) pregnant women, and (e) persons of specific race and ethnicity.
Interventions
At the present time, no standardized testing procedures exist for CIs in patients with
clinical symptoms of VF. This project aimed to educate PCPs at four rural health clinics in
Selma, Hanford, Reedley, and Tulare, California on VF’s epidemiological history, pathology,
symptoms, risk factors, testing, diagnosis, and treatment. The interventional tools were
PowerPoint slides, a training manual, and an algorithm pathway for VF. The training manual and
the algorithm pathway were published by the University of Arizona, College of Medicine
Tucson: Valley Fever Center for Excellence.
Stakeholders
The key stakeholders were the project manager (DNP author), AHCVN clinic providers
and AHWs, Marketing Medical Director for the Central Valley Network, Administrative
Executive Assistant, Vice President in Population Health, Department of Occupational Health –
CDPH, and the Senior Administrative Assistant. The stakeholders, particularly the Marketing
Medical Director of the Central Valley Network, Administrator of Occupational Health from the
CDPH, and the Vice President of Population Health, welcomed this educational program.
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Gap Analysis
A gap analysis was conducted in Fresno County at a primary care clinic that serves
middle to low-income patients and a large population of patients who have state health
insurance. Efforts were aimed at patients who lived and worked in the Central Valley in soil
disturbing occupations and/or lived near high dust areas, making for potential exposure to
coccidioides spores. Current literature and clinical practices in the primary care setting indicate
that providers do not see that the prevalence or have adequate education of CIs in the Central
Valley that should necessitate screening for VF in high-risk populations. Additionally, a gap in
care was identified by both the Marketing Director of Adventist Health and the Vice President
Administrator in Population health, who have indicated the need for more VF education for their
patients at AHCVN (Appendix C). Additionally, current clinical practices in the Central Valley
have no specific criteria or standardized guidelines for correctly screening, diagnosing, and
effectively treating VF. Furthermore, research has indicated a lack of education and knowledge
on the prevention, disease pathology, and early detection of CIs. This neglected disease, endemic
to Central California, has prompted the current research and practice recommendations.
Objectives
This project aimed to (a) define CI and its pathogenesis, (b) review the symptoms of a CI,
(c) assess individual risk factors and vulnerable groups, (d) promote disease preventions, and (e)
review the outlined algorithm for treatment. The education session was conducted virtually at
AHCVN’s four family practice clinics.
The educational session was held at a lunch hour education series for providers via
Microsoft Teams meeting application. The educator used a PowerPoint presentation and
distributed a management algorithm for uncomplicated VF. Additional educational sessions were
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offered by the DNP student to increase the knowledge on VF to a larger population of PCPs
(Appendix D). The invitation remains open to repeat another educational session if there is
interest from the AHCVN providers or their affiliated clinics.
Prevention Measures
The research suggests that prevention and education for PCPs, employers, and vulnerable
communities are key to preventing, reducing, and treating VF, thus reducing morbidity and early
mortality. Existing clinical practices around the Valley have no specific criteria or guidelines on
how to correctly diagnose, screen, and treat VF. The statistics reported by Tartof et al. (2018)
showed that medical specialties, such as infectious disease and pulmonary medicine, have more
awareness and knowledge about VF, resulting in higher testing rates and earlier diagnosis.
However, specialty medicine referrals are obstacles for those with no health insurance, state
funded insurance, or no access to them (Tartof et al., 2018). It is imperative to educate PCPs who
serve disenfranchised communities who are more likely to labor in soil-disturbing occupations.
Gantt Chart
A Gantt chart provided a schedule for planning, coordinating, assigning, and tracking
specific tasks required for the project. The Gantt chart outlined the development,
implementation, and evaluation timeline for the project (Appendix E). The project began in
September 2018 with a literature search on VF, and a clinical site was secured with Spruce
Multispecialty Group (SMG), an internal medicine clinic in Fresno, California. The SMG
consisted of six internists who approved the project. The author was a former employee at this
clinic and was granted permission to conduct the DNP project. Unfortunately, this site was lost
due to the author leaving to pursue family practice medicine at another local clinic in Fresno,
California. Consequently, the DNP project was suspended until January of 2020, when another
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clinic was secured. Prior to the clinical site affiliation agreement with the University of San
Francisco, the California Department of Public Health (CDPH) was contacted in September of
2019 to investigate a need for VF education in rural clinics in the Central Valley. A two-hour
Zoom meeting connected the DNP author; the author’s project committee advisor, Dr. Juli
Maxworthy; and Mary Deems from the occupational health (OH) branch at the CDPH. The
administrator of occupational health from the CDPH indicated a current dearth of VF education
occurring in the outreach clinics in the Central Valley and endorsed this project with great
enthusiasm. In February of 2020, a new clinical site was established with Adventist Health and
the project resumed on February 11th, 2020 with a telephone call to the Vice President in
Population Health, Nina Plata. Following initiation of the project, a Skype meeting was held with
the Marketing Medical Director, Dr. Ayala; Vice President in Population Health, Nina Plata; and
the project manager (DNP author) on March 13th, 2020. On June 17th, 2020, the DNP author
held a telehealth meeting with the lead stakeholder, Dr. Ayala, regarding educational content
needed for his providers. Dr. Ayala requested accreditation with either Loma Linda University or
with the American Academy of Family Physicians (AAFP). At this time, it was decided by Dr.
Ayala that the education session must be conducted virtually due to the COVID-19 pandemic.
On July 19th, 2020, an application was submitted to the AAFP for accreditation and for a
continuous medical education credit (CME) hour. The VF project was accredited and approved
for 1.0 CME hour on August 10, 2020. Two weeks prior to the educational program, August
12th, 2020, an electronic flyer was emailed to all the Central Valley Network providers at
AHCVN regarding the educational program on VF.
Before the educational session, pre knowledge surveys were electronically available via
Qualtrics from August 12th, 2020 to August 26th at 12 PM. The VF project was implemented
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virtually on August 26th, 2020 from 12 PM – 1 PM. Post knowledge and satisfaction surveys
were electronically available via Qualtrics from August 26th to August 31st, 2020. Two weeks
after the educational session, printed materials on patient education for VF, pamphlets in both
English and Spanish, and VF algorithm guides were delivered to the administration center in
Hanford, California. A link on The Valley Fever Training manual for Primary Care Providers
was emailed to Dr. Ayala after the educational session for his reference. On December 1, 2020,
the results of the educational and satisfaction surveys were sent to Dr. Ayala and Mary Deems.
Work Breakdown Structure
The project’s work breakdown structure (WBS) included tools for communication,
resources, and costs. The project’s WBS helped identify how the objectives and goals of the
educational program would be accomplished by certain tasks in a specified timeframe (Moran et
al., 2020). The WBS model has five phases: (a) initiation, (b) planning, (c) execution, (d) control,
and (e) closeout. The VF project aimed to improve clinical practice guidelines for the PCPs at
AHCVN, California on the detection and treatment of CIs in high-risk individuals who live and
work near soil disturbing activities. Educational activities included a pre- and post-knowledge
survey on VF. Educational materials included PowerPoint slides, a diagnostic and treatment
algorithm on CI and VF diagnosis, and VF treatment manuals. Regular emails, telephone
conversations, and virtual meetings were conducted over the six months. On August 26, 2020, a
virtual teaching session during the providers’ lunch hour was held and concluded with questions,
acknowledgements, and credits. Immediately following the teaching session, post educational
and satisfaction surveys were emailed to the participants. The objectives were met through a PCP
educational program on VF (Appendix F).
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Responsibility/Communication Plan
Communication was through emails, virtual visits, and telephone calls with the
stakeholders. PowerPoint slides, teaching objectives, and outcome results were emailed to the
CDPH and the Marketing Medical Director at AHCVN. All communication between the
stakeholders was confidential and confined to the project’s team members. There was no direct
patient contact from the project manager (DNP author) because the data collection was on the
educational needs and goals from the providers themselves; therefore, the Health Insurance
Portability and Accountability Act (HIPAA) remained intact. The clinic’s intranet system will
allow for communication among the team members and stakeholders. All information, including
data, educational materials, and stakeholders’ names were archived at the end of the project.
This project had no ethical issues to consider. However, adhering to ethical guidelines
governed by the American Nurses Association Code of Ethics allowed for honest, accurate, and
transparent communication among the stakeholders regarding objectives, information, and
perspectives (ANA, 2015). Ethical communication principles applied to the project were credible
and promoted trust among the stakeholders. Quality communication could have been jeopardized
had the values, beliefs, knowledge, and personal goals of individuals differed from the values,
beliefs, and objectives of the project manager (Appendix G). In addition to the nursing ethics,
Cura personalis is the Jesuit value that was integrated into the project’s ethos. Cura personalis
treats the whole person physically, mentally and spiritually (Creighton University, 2019). The
Jesuit principles are driven towards communities that are marginalized and disenfranchised, and
who may face unique challenges.
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SWOT Analysis
Strengths, weaknesses, opportunities, and threats should always be considered in any
project. The following SWOT analysis describes these factors in relation to the stakeholders
involved at AHCVN and their potential to affect implementation (Appendix H).
Strengths
The biggest strength of the VF project was the improved efficiency and accuracy of the
organization’s screening, diagnosing, and managing of VF. The injection of knowledge and new
practice guidelines at the Central Valley Network will eventually infiltrate and benefit other
similar communities in the Central Valley, thus accomplishing Healthy People 2020’s
(USDHHS, 2018a) goals of improving the nation’s environmental health. The most substantial
strength, however, was the improved treatment and illness trajectory times of individuals
affected by CIs. PCPs have new knowledge on the occupational risk factors that contribute to
respiratory infections, thus prompting them to investigate for a possible CI.
Weaknesses
The weaknesses projected on the management of VF cases are the language and
knowledge barriers of the population, affordability of services, and access to healthcare; hence
the possible failure to report or capture populations infected with cocci. The major weaknesses
are due to the lack of citizenship and legal residency of this particular population, who are
mainly farm workers in the agricultural community. Another weakness is patient compliance
with the lengthy treatment regimen, which rated high on the satisfaction survey. PCP resistance
due to lack of time and availability was not evident, as anticipated, due to the large number of
participants who attended the educational session.
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Opportunities
Future opportunities exist for policy change and the publication of VF as a national
concern in the healthcare media; thus, informing the medical profession of the disease through
enforcement in the academic medical curriculum is an imperative. In addition to make the public
aware of the disease, a public health care initiative must be incorporated into the Healthy People
2020 goals. Furthermore, the CDC and CDPH can negate the need for mandatory education for
PCPs in the Central Valley. Moreover, this project offered 1.0 CME credit hour and was
accredited by the AAFP. It is important to note that epidemiology and immunology are ripe for
funding research toward more efficient diagnostic tests and an effective vaccine.
Threats
Based on the population of patients seen at AHCVN, a likely threat is patient adherence
to the medical management of VF. This obstacle is founded on poor awareness of VF and
financial weakness, particularly for those who have no insurance or access to healthcare. Another
threat could have been no accreditation by the AAFP, forcing the Medical Marketing Director to
decline implementation of the project at his site, as accreditation and CME components were the
determining factors for acceptance. A threat to implementation could have been a belief among
stakeholders that other concerning health issues superseded VF. This project succeeded in
alleviating these threats.
Study of the Interventions
The pre- and post-knowledge surveys appear to have accurately measured the learning
and retention of the content taught. The surveys used in the VF educational session consisted of
10 multiple choice questions. Additionally, the pre- and post-knowledge questions were
delivered in the same format (a link to Qualtrics) and with the same content, to ensure data
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quality and adequacy. To ensure validity of the data, Qualtrics was used to measure the number
of participants and numerical scoring for all three surveys. The knowledge surveys indicated in
the statistical analysis that learning occurred, with an overall knowledge improvement score of
12.63%. The satisfaction survey employed the same delivery of the questionnaire with a link to
Qualtrics, to confirm that the education was delivered effectively and efficiently. The satisfaction
survey also indicated if the participants would change their practice guidelines to improve health
outcomes in patients diagnosed with VF. The satisfaction survey used a 10-question, 3- to 7point Likert scale to measure provider agreement on the value of the education session, and if
they gained new knowledge that would prompt them to change their current screening,
diagnosing, and managing practices. The satisfaction survey used Qualtrics statistics software to
collect the data and calculate the results. Each participant received the survey immediately after
the education session via email with a Qualtrics link attachment. The satisfaction scores were
analyzed to be 100% in agreement to change the current practice and commitment to implement
the new guidelines in their clinical practice. Moreover, they were satisfied with the delivery
method of the educational session. Through this project, PCP knowledge on VF increased, and it
is predicted that interventions among susceptible individuals will increase as well, reducing
illness morbidity and related healthcare expenditures.
Budget
The direct costs of the project were estimated, and covered travel, printing, and time
spent by the DNP author. The providers and administrative staff were not included in the budget
because the educational session was done during the providers’ unpaid lunch hour. The budget
calculated for travel included mileage, as allowed by Internal Revenue Service rate (IRS, 2019),
and fuel. The DNP author’s salary was calculated at a rate of $62.50/hour x 10 hours a week, for
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24 weeks, at a cost of $15,000. Additional costs were allocated for printing of patient education
pamphlets on VF in both Spanish and English and algorithm reference sheets ($140.00) and the
AAFP membership fee for the project’s course accreditation ($295). The cost for visiting the
Hanford clinic to deliver the printed materials, at 0.58 cents/mile x 92 miles round trip, was
$53.36, with $20 for gas. The overall cost to implement this project at AHCVN for 40 providers
who attended the education was approximately $15,508.36. Setting up the Microsoft Teams
meeting link was included in the organization’s intranet communication system and incurred no
additional costs (Appendix I).
Measures
Evidence-based common clinical scenarios in high-risk groups with a diagnosis of VF
were used to educate the providers on the course of recommended treatments published by the
Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Treatment of
Coccidioidomycosis and by The University of Arizona, College of Medicine Tucson, Valley Fever
Center for Excellence. The educational session was delivered virtually via Microsoft Teams. At
the end of the educational session, 1.0 unit of CME was given to all participants. The DNP
project was accredited by the AAFP.
Outcomes were measured by statistical analysis of the providers’ knowledge on VF. Pre
educational survey results were compared to the post educational survey results. Qualtrics was
used to analyze the data from pre- and post-educational and provider satisfaction surveys. The
survey questions included a 10-item questionnaire using a multiple-choice format (Appendix J).
The outcome was increased knowledge on the pathology, screening, diagnosis, and treatment of
VF. The pre-educational surveys showed an overall average score on disease etiology, diagnosis,
and treatment of 69.87%. The post educational survey results showed an overall average score of
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82.50% on the same disease components. The difference in the pre- and post-educational scores
indicated a 12.63% increase in provider knowledge. A post educational satisfaction survey
distributed used multiple-choice questions and a three to seven-point Likert scale (Strongly agree
to Strongly disagree), and “yes,” “maybe,” and “no” (Appendix K). Predicted screening rates for
VF increased by 30% based on the satisfaction survey results. The provider satisfaction survey
allowed for feedback on the design and implementation of the DNP project. To evaluate the
implementation of a change in practice outcome, a continuous quality improvement (CQI)
analysis must be in the program. Evaluation is imperative to understanding how the practice
improvement project improved patient outcomes for a specific illness or disease. The USDHHS
(2018b) stated that any change in healthcare practices or programs must identify key successes,
challenges, and lessons learned. It is helpful to use these data to monitor the newly implemented
program’s improvement of patient outcomes (Appendix L). The CQI was not measured in this
practice improvement project due to the length of the DNP program and the extended timeframe
to track improvements in the health outcomes in VF patients.
Cost/Benefit Analysis
The implementation of the VF educational program for PCPs at AHCVN helped alleviate
the unnecessary use of healthcare dollars based on the following statistics: 80% of AHCVN
patients are Medi-Cal, and the main industry in the Central Valley is agriculture. The planned
education session required one hour of the provider’s unpaid time. According to recent statistics,
there are roughly 400,000 agricultural workers in California, and half of these farm workers are
undocumented. According to Greenberg (2018), California’s San Joaquin Valley is one of the
highest valued stretches of farmland in the country, if not the world and, it is dependent on a
labor force of largely undocumented migrant workers (Appendix M). The AHCVN practice
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administrator reported that 80% of their patients have Medi-Cal and the rest are members of
preferred provider organizations (PPOs) or health maintenance organizations (HMOs); they were
unable to give exact figures on this information. While not all Medi-Cal patients work in
agriculture, considering the literature review, it is likely that the majority of them do.
As of April 2020, the CDPH reported a total of 2,053 VF cases in California, though not
all had dissemination or complicated disease. Wilson et al. (2019) reported that 60% of VF
patients were asymptomatic, while the remaining 40% had self-limiting respiratory illnesses,
life-threatening pneumonia, meningeal infections, or dissemination of disease. These percentages
concurred with other studies reviewed. The Central Valley Network clinics were located in the
agricultural comminutes of Hanford, Reedley, Selma, and Tulare, CA.
One cannot predict the average number of agricultural workers in the surrounding
communities, but by using the CDPH statistics, the costs were predicted from the numbers given.
Farm workers are known to be migratory, taking on seasonal work while moving from county to
county, so measurements on cost are only estimates (Greenberg, 2018). Using Wilson’s (2019)
and the CDPH’s (2020) statistics for calculating the current VF cases in California as of April
2020 (n = 2,053), the cost calculation is 2,053 x $1,023,730 per person lifetime direct cost
burden for disseminated cocci = $2,101,717,690, and for uncomplicated cocci with pneumonia is
2,053 VF cases x $22,039 per person lifetime direct cost burden = $45,246,067. The total direct
cost burden for both disseminated disease and uncomplicated cocci with pneumonia is
$2,146,963,757. The cost burden without intervention is astronomical, especially for a disease
that is geographically confined to endemic areas. The return on investment (ROI) for provider
knowledge outweighs the cost burden for the treatment of VF. Just to reiterate, 60% of patients
with VF are asymptomatic, implying that these patients would not seek care and not get tested
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for cocci. The data presented by the CDPH was assumed to represent the 40% of symptomatic
patients who sought care for multiple complaints of respiratory illnesses or other CI
complications, which resulted in them getting tested for cocci.
The projected three-year proforma of 8.3% per year reduction in direct healthcare dollars
to be $178,197,992 ($2,146,962,679,500 x 8.3%). Total 3-year proforma at 25% reduction in
direct healthcare expenditure is $534,593,976 per person lifetime direct cost burden
($178,197,992 x 3 years at 8.3% reduction). As the direct cost burden decreases, so will the
indirect costs burden for patients with VF. The indirect costs calculated using Wilson’s (2019)
statistics of $36,298 per person and the number of VF cases published by the CDPH for April
2020 (2,053) will equal $74,519,555 ($36,298 x 2,053). At 8.3% reduction per year for the
indirect costs, the projected reduction will be $3,012.73 per person; at 25%, the indirect costs
burden over three years will be $9,038.19. The financial forecast on the VF education program
was designed to reduce expenses in healthcare. There was no financial gain to the organization;
therefore, it was not revenue producing (Appendix N).
The evidence-based practice improvement intervention was an educational program for
the providers and AHWs at AHCVN on how to select specific populations for screening,
diagnosing, and treating of VF. The goal of this educational program was to promote effective
and accurate diagnosis and treatment of VF through early screening of symptomatic high-risk
individuals, thereby reducing healthcare expenditures and improving patient outcomes. The
intervention sought to increase provider knowledge by 90% on VF and reduce direct and indirect
healthcare expenditures by 25% in a three-year proforma. In a recent study, the total lifetime cost
burden in California for 2017 for reported cocci cases, n = 7466, was just under $700 million
(discounted), with $429 million in direct costs (diagnosis, treatment, medications,
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hospitalizations, and physician follow-up visits) and $271 million in indirect costs (lost days of
work-, short- and long-term disability, and mortality costs). These figures were based on a costof-illness study done in 2017 by Wilson et al. (2019). The healthcare expenditure breakdown per
person for lifetime for 2017 for patients with disseminated disease was $1,023,730; and $22,039
for patients with uncomplicated cocci with pneumonia. These costs did not include the indirect
costs incurred by employers from lost days of work and disability payments. The above
healthcare expenditures included initial diagnosis, follow-up visits, treatment procedures,
medications, hospitalizations, and home care and nursing home care (Wilson et al., 2019). The
current intervention will likely reduce these expenditures significantly if providers educate their
patients on VF precautions and diagnose and treat them expeditiously.
Ethical Considerations
The American Nurses Association (ANA) Code of Ethics (COE) has guided the project
manager’s (DNP author) nursing considerations and the implementation teaching program for
VF. The ANA COEs act upon the foundation of nursing theory, practice, and praxis (ANA,
2015). As the momentum on this VF project moved forward, it essentially implied and utilized
the more notable COEs. The first one being provision 1.5: relationships with colleagues and
others, and as such, it established a trusting and professional relationship with the stakeholders.
Provision 1.5 states that nurses and colleagues will create an environment for learning whilst
displaying respect and civility for the sake of the value of nursing and how it can affect patient
outcomes (ANA, 2015).
The second provision is 2.3: collaboration. The active participation of the project
manager (DNP author) and the stakeholders fostered a quality of care that was conducive to
positive patient outcomes—in this case outcomes of infected individuals. A collaborative effort
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among all the stakeholders facilitated a provider-based educational program to diagnose and treat
the Central Valley population effectively. According to the ANA COEs, collaboration must have
mutual respect, recognition, transparency, shared decision making, and open communication
among all involved individuals in this project (ANA, 2015).
The third provision is 7.1: Nursing contributions through research and scholarly inquiry.
Through this act of scholarly inquiry, that is, the gap in the misdiagnosis of VF, the project
manager (DNP author) engaged in research and scholarly work to expand the body of knowledge
on VF to set new policy and practice guidelines to ameliorate the effects of VF risks and
morbidity. In the future, provision 7.1 could lead to provision 7.3: contributions through nursing
health policy development. This provision allows nurses to advocate and establish new
healthcare policies for the protection of human health and well-being. As with VF, promoting a
secondary prevention measure to diagnose and appropriately treat this disease in the infectious
stage will reduce its morbidity and mortality. These are just a few major provisions mentioned ;
however, there are many provisions in the ANA COEs that this project could have employed.
In keeping with the Jesuit principles, the University of San Francisco’s mission to deliver
holistic care concurs with the Jesuit order to provide a humanistic vision of care that includes a
faith-based leadership to educate people on the principles of justice, respect, and care for the
poor and marginalized. Consecutively, the principles and values of the Jesuit Order and the
university’s mission concurs with AHCVN’s mission, vision, and values. AHCVN is a faithbased organization that serves their communities through enhanced healthcare delivery systems
and by inspiring health, wholeness, and hope. The organization holds to their values of integrity,
respect, compassion, and excellence through the faith-based standards of behavior by their
employees (Adventist Health, 2020). Additionally, the care given to the populations of need must
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be delivered with critical thought and responsible adherence to moral and ethical concerns. The
Jesuit values of God and faith broadens a nurse’s understanding of cultural and global
differences and increases their knowledge to engage in municipal and national affairs to improve
healthcare outcomes to all populations (Creighton University, 2019).
The Doctor of Nursing Project (DNP) targeted the needs of the community AHCVN
serves, and based on the organization’s community benefit program, which is assessed every
three years, coincided with this quality improvement project. AHCVN’s Community Health
Needs Assessment stipulates improving the health and well-being for their community by
partnering with community organizations, providers, educators, businesses, and the populations
they serve. One of the organization’s goals is to understand the health behaviors, risk factors, and
social determinants that impact health (2020, August 5, AdventistHealth.org). The DNP project
delivered the targeted needs of the organization.
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Section IV: Results
Forty providers from AHCVN California participated in the educational training session
on VF. The providers attended the education session during their lunch hour virtually using a
Microsoft Teams application software system. Pre and post knowledge survey results on etiology,
disease process, transmission, and management before the activity are shown in the appendices
(Figure 1, Appendix O). Results are compared in percentages of correct responses via Qualtrics
statistical analysis. The pre- and post-knowledge questions appear above each bar graph (Figures
2-11, Appendix P; Figures 12-21, Appendix Q). The questions on the surveys were multiple
choice, with two to seven choices, with some questions having more than one correct answer. For
question one, “The Central Valley is considered highly endemic for cocci” there was no change in
knowledge, both pre and post results showed 100% as true, the correct answer. Question two, “In
the environment the coccidioides spore is a”, on the pre knowledge survey the correct answer was
fungus, 84.62% of the participants got the answer correct, this was compared to the post survey
response of 100%, there was a 15.38% increase in knowledge. Question three, “What is the mode
of transmission of cocci?” with the pre survey result showed 76.92% of correct responses
compared to the post survey result of 87.50%. Question four, “What are the major clinical
symptoms of VF?“ Pre survey results showed 84.62% had correct responses compared to the post
survey results of 100%, a 15.38% increase in knowledge. Question five, “Risk factors for VF “,
pre survey result showed 82.62% of correct responses compared to the post survey result of 100%
of correct responses, a 17.38 % increase in knowledge. Question six, “Testing patients with a
possible acute cocci infection, what initial diagnostic tests would you order?” with the pre survey
results showed a calculated average of 90.63% of the respondents got the correct answers, this was
compared to the post survey results as a calculated average of 87.50% of the correct responses, a
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decrease in learning score of 3.13%. Question seven, “A negative serologic test for cocci should
exclude the patient as having a cocci infection after the first serology test”, the pre survey result
was 83.33% of correct responses compared to the post survey result of 100%, there was a 28.85%
increase in knowledge. Question eight, “Patients who present with mild symptoms or who are
asymptomatic with a positive cocci result, should you initiate treatment?”. The pre survey correct
responses was 46.15% compared to the post survey correct response of 75%, a 28.85% increase in
knowledge. Question nine, “Patients who are newly diagnosed with VF and are symptomatic, what
is the primary drug treatment?” with the pre survey results showed 76.92% of correct responses,
compared to the post survey results of 87.50% of correct responses, a 10.58% increase in
knowledge. Question ten, “How long should a patient diagnosed with VF be on surveillance?”
with the pre survey of correct responses was 61.54% compared to the post survey results of 75%
of correct responses, a 13.46% increase in knowledge. Of the 40 participants, only 13 responded
to the pre-educational session and only eight responded to the post educational session, but there
were significant outcomes between the two comparison groups based on the post survey results
that the learning objectives were successfully met.
The bar graphs representing responses for each question on the pre-educational survey
are in the appendices (Figures 2-11, Appendix P). On the pre knowledge questionnaire, the
average score for correct answers is 78.93% of the 13 participants. The post knowledge results
average score from 8 responses is 91.25% of correct answers. The difference in scores from the
two surveys represents a 12.63% increase in knowledge post session (Figures 12-21, Appendix
Q).
The data analysis extrapolated from the surveys used a 95% confidence interval. There
were no comparison groups, but only one group of participants at different subsequent points in
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time pre/post comparison to test improvement in knowledge postintervention. The validity of the
instrument used to collect the data was a knowledge survey that contained the same questions
preintervention and postintervention. The surveys maintained accurate reliability and validity
with the same tool (survey) to measure knowledge by using objective answers for each question
that addressed the aim of the project. The DNP project was implemented to improve care and
illness outcomes for all patients who presented with clinical symptoms of cocci. Subsequently,
this project also provided the PCPs with current evidence-based literature to standardize their
care for all patients at AHCVN.
The data analyses are summarized in the tables using a satisfaction scale of the content
taught. A three to seven-point Likert scale was used to quantify the results in percentages
(Figures 22-31, Appendix R). A summary of results showed that 75% of the participants strongly
agreed that the presenter had proficient knowledge on the content taught and 50% of the
participants strongly agreed that the virtual format was appropriate for the educational session.
However, 25% of the respondents disagreed with the virtual format. Sixty-two and half percent
of the respondents felt that the learning objectives were achieved and 75% strongly agreed the
material was organized clearly for learning to occur, the content learned from this activity will
have an impact on their practice and healthcare team, 50% strongly agreed and 50% of the
participants agreed (Table 1, Appendix R). Level of improvement in practice, there were three
choices, competence, performance and patient outcomes. The survey results indicate 40% will
improve provider competence, 30% will improve provider performance and 30% will improve
patient outcomes (Table 2, Appendix R). Strategies of treatment, the choices were: (1) Modify
treatment plans, (2) Change my screening prevention practices, (3) Incorporate different
diagnostic strategies into the patient evaluation and (4) None, this activity validated the current
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practice. Twenty percent of the respondents plan to modify their current treatment plans, 30% of
the respondents plan on changing their screening and prevention practices, 50% of the
respondents plan to incorporate different diagnostic strategies and 0% responded that this activity
validated their current practice (Table 3, Appendix R). Level of commitment to new guidelines
for VF survey results were extremely favorable that all the respondents (100%) were very
committed in making clinical practice changes (Table 4, Appendix R). Survey results in
improvement of patient outcomes showed 100% of the participants agreed that this learning
activity will promote implement in healthcare and/or patient outcomes (Table 5, Appendix R).
Current barriers in clinical practice that may impact patient outcomes, there were seven choices
for the participants to choose from. Patient adherence or compliance was the major barrier,
38.46% of the providers felt that this would impact patient outcomes. Time taken in clinical
practice by the providers was another barrier that could impact patient outcomes. The patient’s
insurance was another significant barrier that could impede positive patient outcomes, 30.77% of
respondents chose this barrier. Strongly, 0% of the respondents felt that there was a lack of
evidence-based guidelines that would contribute to the barriers in clinical practice (Table 6,
Appendix R).
The satisfaction survey results indicate a future potential increase in the providers’ level
of commitment to changing practices and a belief that the changes will improve patient
outcomes. This educational session did not immediately change clinical practices, but the high
commitment scores are encouraging. There were no unintended consequences, nor were there
any failures or additional costs. The intended benefit was achieved among the PCPs in VF
knowledge and acceptable guidelines. As stated earlier, a continuous quality improvement
analysis would need to be conducted to measure long-term effectiveness. All data were
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accounted for, other than the lack of completed surveys from the participants. Of 40 participants,
only 13 responded to the pre knowledge survey and only eight responded to the post knowledge
survey.
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Section V: Discussion
Summary
This VF project for PCPs aimed to increase their knowledge of the disease’s ethology,
pathology, diagnosis and treatment. To do this accurately, it was imperative to initiate a
standardized screening tool, guidelines, and management protocols to increase screening rates
and early treatment in vulnerable, at-risk populations. An algorithm was used to guide the
providers on evaluating the steps needed to diagnose and manage VF (Appendix S). The online
virtual education session targeted PCPs at AHCVN. The ultimate goal was to evaluate and
consider CIs in high-risk populations who live and work around soil and dust disturbing
activities. The aim was measured by the post knowledge and satisfaction surveys with improved
knowledge scores on VF etiology, pathology, disease process, diagnosis, and treatment. The
satisfaction scores represented strong commitments to changing practices with vulnerable groups
who have occupational exposure to dust. If PCPs consider VF in the differential diagnoses,
patients will receive more effective and efficient treatment for their symptoms in the primary
care setting. In addition to the education provided to the PCPs at AHCVN, patient education was
incorporated into the learning objectives. Patient education about the signs and symptoms of VF
and its risk factors was key to the education process so the PCPs themselves could educate their
patients on when to seek medical care.
A CME certificate was distributed to the participants after the education session and
surveys were completed (Appendix T). Provider education that is CME accredited with the
AAFP has allowed for credible dissemination of knowledge on VF among the providers at
AHCVN and to the providers to other Adventist Health clinics statewide. With the
implementation of this educational session, the organization decided to initiate monthly lunch-
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hour education sessions on various illnesses and diseases that are commonly seen in primary
care, making this DNP project the first of a monthly education series.
Bilingual patient information pamphlets were delivered two weeks after the educational
event (Appendices U & V) and represented another key component in the dissemination of
knowledge to the public and the improvement of reporting practices. The educational session
was advertised with an electronic flyer and was sent out to all the PCPs and AHWs two weeks
prior to the scheduled event (Appendix W).
The implications for advanced nursing practice identified by this DNP project are
improved health outcomes in patients, thus leading to a clinical change in practice in populations
with a specific disease. Disseminating knowledge in the primary care sector provided an avenue
for advocacy on health policy. Additionally, a patient case scenario on VF, written by the author
about CIs and what PCPs need to know, was recently published in an online nursing journal for
nurse practitioners called “Cocci Are in the Air” (Bergen, 2020) published in the October issue
in the Journal for Nurse Practitioners (JNP). This project did not receive any external funding for
the work conducted through its entirety.
Interpretation
The results from the knowledge surveys clearly indicated that learning occurred. The post
knowledge survey results indicated increased knowledge of VF etiology, mode of transmission,
presenting clinical symptoms, risk factors for contracting VF, methods of diagnoses, and
management of the disease by 12.63%. The proposed target improvement score was a 15%
increase in provider knowledge, but perhaps this number would have been achieved had more
participants completed the post educational surveys. Tartof et al. (2018) and Benedict et al.
(2018) stated that education is imperative for the accurate diagnosis and management of VF.
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Although postsurvey knowledge increased by 12.63%, no results could be compared to other
reviewed publications.
Overall knowledge improved in every area except with the first question: “The Central
Valley is considered highly endemic for coccidioidomycosis,” as all respondents knew this fact
was true. The largest gain was seen with Question eight, “A negative serological test for
coccidioidomycosis should exclude the patient as having a coccidioidal infection after the first
serology testing.” All the post survey responders answered correctly as false. The improvement
scores were significant, which indicated that the participants retained the knowledge and showed
potential improvement in screening patients sooner and managing them appropriately.
Additionally, statistical evidence showed low standard deviations and low variances around the
mean, indicating the reliability of the data, with minimal variability and high reliability.
Common VF clinical case scenarios were used to explain the disease interventions more clearly.
These case scenarios were common and relative examples on current clinical representations that
occur in the primary care setting. Case scenarios were more effective in conveying the content
rather than reiterating the literature. The clinical case studies were used from the Clinical
Practice Guideline for the Treatment of Coccidioidomycosis published in the Infectious Diseases
Society of America (IDSA) Journal (2016). Collaboration of the evidence from the literature
review and information from a number of credible resources provided current and novel
information for a successful implementation of the VF project. The AAFP accreditation delayed
the launch date by 1 month. In retrospect, it was valuable to have this accreditation with the
AAFP, as this educational program for providers was critically reviewed by the board and editors
of the organization to ensure evidenced-based content and improved health for patients, families,
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and communities. The accreditation allowed this educational program to be transferable and
applicable to similar audiences.
The satisfaction survey results were extremely positive. Presenter knowledge of the
content garnered 75% Strongly agree and 25% Agree. The virtual format of delivery of the
education got mixed reviews (see Table 1, Appendix R). The level of improvement in practice
showed 100% regarding competence, performance, and improved patient outcomes with a
diagnosis of VF. The strategies in treatment showed good scores, where providers planned to
modify their treatment plans, screening, and prevention approaches, and patient evaluations by
considering VF in the differential diagnosis. Level of commitment to follow the new guidelines
and their perception that these new guidelines will improve healthcare and patient outcomes was
100%. The outstanding barriers to favorable patient outcomes that the PCPs faced in their current
practice at AHCVN were patient adherence/compliance to the treatment regime for VF (38.46%)
and patient insurance (30.77%). This was an understandable prediction because 80% of the
patients who are served by the Central Valley network providers are of low income, insured by
Medi-Cal, and/or who are uninsured or undocumented immigrants.
Overall, the findings supported the conceptual framework that was chosen to guide this
project: The Conceptual Model of Nursing and Population Health. This model of care
incorporates the nursing activities of health promotion and secondary disease prevention; uses
upstream factors, such as the population’s occupational environments; it defined population
factors, such as the genetic makeup of certain ethnicities who were more at risk of acquiring a CI
in a specific geographical range; and it used the healthcare system factors by collaborating and
connecting with the four rural clinics that serve the agricultural communities of the Central
Valley. This model, according to Fawcett and Ellenbecker (2015), addressed a population’s
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health problem within a specific geography and a defined population with a CI. Educating the
providers at AHCVN has the potential to exponentially propagate new knowledge due to its
state-wide platform of family practice and specialty clinics. The education program delivered a
disease and illness prevention model theory on population health and endorsed nursing
leadership by working with partners and organizations to improve the delivery of quality care,
and to meet unique challenges in healthcare. The CME activity encouraged staff and professional
development through an accredited educational program discerned by the AAFP.
Limitations
The recent COVID-19 crisis and resulting social distancing limited the DNP student’s
face-to-face encounters with the project participants. This was noted in the statistical analysis, as
the virtual format of the education session received strong agreement by only 50% of the
respondents. The number of the clinic’s PCPs who participated in the educational session was
significant and will impact the potential dissemination of new knowledge to other affiliated
clinics. Although only 13 responded to the pre intervention survey and only eight to the post
intervention survey, the results were sufficiently significant for propagation of knowledge. There
was a strong correlation among the dependent (VF knowledge) and independent (education)
variables despite the small sample size of survey respondents. The large sample size (number of
participants) did not represent the number of survey responses received ; in other words, the size
of the effect and the size of the survey responses affected the sensitivity of the effect (the
intervention), making the statistical power low. The number of participants who attended were
adequate; however, many neglected to complete the pre and post educational surveys. The
education session was not registered on the AAFP website, a place to access education credits,
possibly contributing to the reduced number of completed surveys. Registering on the AAFP
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website as a CME credit would have allowed completed surveys to automatically populate the
CME certificate once the required information and affiliation to AHCVN had been added. As
such, the project manager was obligated to distribute the CME certificate after the education
session was over. The registration was omitted by the DNP author due to cost and time. The
education program was scheduled for August 26, 2020 from 12:00 PM – 1:00 PM, with the pre
educational surveys being distributed 13 days prior to the event and available for completion
until 12:00 PM on the day of the event. The post educational survey was opened at 2:00 PM on
the day of the event and closed at 4:00 PM, August 31, 2020. After the educational event, the
DNP project manager received emails from the participants who were wanting their CME credit
for attending the educational event. In retrospect, registering on the AAFP website would have
permitted CME certification only upon completion of the post education survey.
The project measured the increase in knowledge on VF using objective data; therefore,
inferential statistics were applied to make a prediction that the results observed in this sample of
population of providers will likely have the same effect for PCPs in similar care settings and with
similar populations. The results showed predicted outcomes and supported the conceptual model
theory that educational workshops on specific health topics will likely improve knowledge and
health outcomes for all populations.
The Internal Review Board (IRB) approval was not required for the implementation of
this project; a DNP Statement of Non-Research Determination form to the DNP Committee is
included (Appendix X), and the project was supported by the stakeholders of AHCVN
(Appendix Y). The education slides on VF are included in Appendix Z. The author intends to
register the VF education as a CME credit on the AAFP website so that providers who are AAFP
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members can access the information nationwide and disseminate the knowledge on VF even
further.
Conclusions
In synthesizing the evidence and identifying gaps in care, it is apparent that the current
literature supports that CIs are rampant and widespread across the Southwestern United States.
California is considered highly endemic, but the Central Valley has proportionally higher rates of
prevalence and incidence. Populations most susceptible to this disease work in soil disturbance
activities, and the main ones are agriculture and construction. Other vulnerable populations are
persons with low immunity, pregnant women, and persons of color. By educating a small
population of PCPs who care for populations vulnerable to VF, this project should increase early
detection rates of CIs. Furthermore, this education is sustainable and repeatable in similar
populations at risk, as it is based on current high-quality evidence that can affect health policy
and provide for continued research on novel therapies and treatment algorithms. Moreover,
increased knowledge of VF can meet one the goals of Healthy People 2020: improving the
environment of communities who are exposed to this specific airborne illness.
Presently, no vaccine exists for VF, but continued investment in scientific research in
immunology will only aid in the process, which can be prioritized for high-risk individuals. The
gap in the literature revealed a dearth of mandatory published guidelines or education for
providers on CIs. Delayed detection of a CI can result in weeks or months of inappropriate care
and treatments, which can lead to increased rates of morbidity, loss of productivity, and possible
early mortality. Without immunization, early detection is crucial. The strongest
recommendations are in prevention through awareness, education, and occupational safety.

VALLEY FEVER: EDUCATING PROVIDERS

49

The PICOT question addressed the need for a secondary prevention for cocci and was
tailored to a specific population at risk for VF in a defined geographical location. An educational
program on VF was implemented for PCPs at the AHCVN so that critical early screening in
high-risk groups can be accomplished. The data showed a 12.63% knowledge improvement of
VF, with 100% commitment from the providers at AHCVN to make changes to their diagnostic
workups. Using the WBS and Gantt chart allowed for the project’s aim to be specific,
measurable, applicable, realistic, and timely. Adopting the CMNPH approach allows for more
global and population-based prevention and health promotion programming. This approach can
be effective only with strong and skilled leadership who will present evidence and
epidemiological data to address population health priorities and practices.
The short-term outcomes of this change will benefit rural communities with more
accurate diagnoses and treatment and better health outcomes. Long-term implications will mean
that stakeholders recognize and acknowledge that VF is a national health concern requiring
policy change on healthcare practices for all providers treating populations with clinical
symptoms of VF. This policy change was recently legislated by the Governor of California for
construction workers certifying annually on VF risks and symptoms. This modest step in the
right direction is significant enough for the government to recognize that VF negatively impacts
people who live and work around dust. Furthermore, the burdensome cost of delayed diagnoses
is substantiated by strong evidence. The ROI for the direct and indirect cost burden for VF cases
is a substantial $534 million, justifying the expenditures needed to establish standardized
guidelines for the effective screening, diagnosing, and managing of VF. Uninsured patients with
CIs rely on county, state, and hospital funds for their care. The long-term objective of this project
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is to change state policy on medical practices for PCPs in the Central Valley via a mandatory
educational program for testing and treating CIs earlier in the disease course.
This project demonstrated the needs of the providers at the four rural health clinics in the
Central Valley through an accredited learning program on VF to improve their competency in
treating patients with clinical symptoms of VF. Educating the patient population who present at
the four AHCVN clinics will increase their awareness of the risks and symptoms of VF so they
can know to seek medical care earlier in the disease process.
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Section VII: Appendices

Appendix A: Evidence Table
Citation
Benedict, K. et al. (2018). Emerging Infectious Diseases, 24(8), 1444-1452.
Purpose of Study
Surveillance study of cocci infections comparing 14 low and nonendemic states to that of Arizona and California, which are known to be highly endemic for valley fever.
Residents who travel from a low or nonendemic state to either Arizona or California had more disease occurrence.
Design/Method
Quasi-experimental design.
Sample/Setting
Study occurred during January 1 December 31, 2016. Routine surveillance study was conducted in 14 states in the United States with 339 participants with a selfadministered questionnaire on: Symptoms, healthcare behavior, diagnosis, treatment, outcomes, comorbidities and travel history.
Major Variables
Rates of cocci infections were compared with low-endemic and nonendemic states to that of Arizona and California. Comparison was also done with the surveillanced states
on the symptoms, healthcare behavior, diagnosis and treatment outcomes.
Measurement of Major Variables
Incidence rates of cocci infections in low and nonendemic states. Symptoms, healthcare use, diagnosis, treatment outcomes and travel history in low and nonendemic states
were analyzed and compared.
Data Analysis
Frequency tables with CIs and ORs. Descriptive analysis to compare differences. Categorical analysis of the variables was don e using X2 or Fischer exact tests and Wilcox
rank-sum tests to compare variables.
Study Findings, Level & Quality
Cocci infections: 54/339 subjects did not have cocci. The most common symptom was cough 65%, fever 45%, and 70% of patients w ith cocci infections received a diagnosis
for other illnesses before being tested for cocci. 54% of the patients visited a healthcare provider > 3 times before being tested for cocci. Level II design of A quality.
Citation
Cooksey, G. L. et al. (2017). AJPH 107(8), 1296-1303.
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Design/Method
Quasi experimental
Sample/Setting
Self-administered questionnaires mailed out to solar farm workers in California in Dec 2013. 925 mailed out to employees at solar farm A, 2457 mailed out to employees at
solar farm B, and 190 mailed out to employees who worked at both solar farms.
Major Variables
Clinical symptoms of cocci compared to asymptomatic workers. Dust cloud or dust storm. Wetting soil. Protective measures used .
Measurement of Major Variables
Descriptive data and classification on employees’ demographics, employment, work activity, and safety practices at work sites. Measured using a Likert scale.
Data Analysis
Association between employment, work activity, safety practices and clinical cocci using logistic regression to compare clinical cases and asymptomatic workers
Study Findings, Level & Quality
558 subjects completed questionnaires. Most were male, non-Hispanic White and residents of cocci-endemic states, median age 45, 40% were former or current smokers.
45.9% of the employees worked in soil disturbing activity. The study found 89 workers with clinical cocci who were frequently in dust clouds, whereas, frequently wetting the
soil was a protective measure and increasing odds of clinical cocci was reported. Level II study of A quality.
Citation
de Perio, M. A. et al. (2019). International Society for Human and Animal Mycology, (57), 41-45.
Purpose of Study
This is a review article to identify industries that caused recent outbreaks of cocci in California from 2007 -2014. The authors report on 4 areas of cocci outbreaks.
Design/Method
Systemic review of surveillance studies using the San Luis Obispo Public Health Department (SLOPHD) and the California Depart ment of Public Health (CDPH) surveillance
system.
Sample/Setting
San Luis Obispo County 2007: had 10-12 construction crew employees replacing a leaky underground pipe.
Kern County 2008: had 8-10 construction workers widening a box culvert.
Ventura County 2012: had 655 workers at an outdoor filming company
San Luis Obispo County 2011-2014: had 3572 solar farm construction workers working at both or either one of the solar farms.
Major Variables
Burden of illness with cocci infection, prevention and safety practices and dust exposure.
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Measurement of Major Variables
No Variables measured quantitatively.
Data Analysis
San Luis Obispo, 2007: 10/12 crew members had acute pulmonary cocci within 1 month of starting work.
Kern County, 2008: 8/10 construction workers had confirmed cocci by laboratory.
Ventura County, 2012: 10/655 film crew members had clinical symptoms of cocci.
San Luis Obispo County, 2011-2014: 89/3572 solar farm workers had clinical cocci, 44 out of the 89 workers with clinical symptoms confirmed with serology.
Study Findings, Level & Quality
Soil-disturbing industries in endemic regions can cause risk to those individuals who engage in soil-disturbing activities. Prevention
strategies would need to be in place, and employer and employee education on cocci is essential. Administrative policies need to be negotiated to reduce incidence of cocci
infections in industries that cause soil- disturbance in endemic regions. This is a Level IV study of B quality.
Citation
Galgiani, J. N. et al. (2016). Clinical Infectious Diseases: IDSA Guideline, 63, 112-146.
Purpose of Study
Revised and expanded recommendations for diagnosing and managing early coccidioidal infection in common clinical presentation s that would guide providers in treating
special high-risk populations infected with cocci.
Design/Method
Clinical review on practice guidelines. The design of this study included validity, reliability, reproducibility, clinical applicability, clinical flexibility, clarity, multidisciplinary
process, review of evidence and documentation to support the current recommendations on the treatment of valley fever. A literature review was conducted by the panel of
researchers that specifically addressed the management of CIs. The panel developed specific actionable questions with recomme ndations in the management of patients
with special circumstances.
Sample/Setting
No population study sample. Setting was the ISDA Standards and Practice Guidelines Committee who collaborated with partner or ganizations and formed a panel of 16
experts on valley fever.
Major Variables
None
Measurement of Major Variables
No measurements
Data Analysis

VALLEY FEVER: EDUCATING PROVIDERS
Practice guidelines systematically developed using the GRADE system to guide providers in treating and managing special circu mstantial clinical scenarios in patient with
valley fever.
Study Findings, Level & Quality
Reviewed and expanded recommendations in the treatment and management for CIs in specific high -risk groups. Specific clinical scenarios listed with the recommended
diagnostics and treatment modalities. Non-research study, level V design of B quality.
Citation
Johnson, L. et al. (2014). Microbes and Infection 16, 591-600.
Purpose of Study
Assess the current knowledge on VF and approaches to improve prevention, detection and treatment. Vulnerable populations acknowledged.
Design/Method
Review article
Sample/Setting
Review of pathophysiology, geography, rates of hospitalizations in California, populations affected, occupational exposures, diagnosis and treatment, vaccines and
recommendations.
Major Variables
No variables studied.
Measurement of Major Variables
No measurements
Data Analysis
Analyzed data and on incidence and prevalence.
Study Findings, Level & Quality
The appropriate use of diagnostics and treatments, with the strongest recommendations made on prevention through awareness an d early detection. Level IV study of B
quality.
Citation
Kirkland, T. N. (2016). Journal of Fungi, 2(34), 1-10.
Purpose of Study
The purpose of this article is to review efforts made to develop a vaccine against cocci.
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Design/Method
Review of the disease process, pathophysiology symptoms and attempted vaccine trials. Reported on a double-blind study on a human vaccine trial conducted in the
1980’s.
Sample/Setting
No setting. It was a literature review on vaccines and the pathophysiology of cocci.
Major Variables
None
Measurement of Major Variables
No variables
Data Analysis
Reported efforts to develop a vaccine against cocci and its difficulties in identifying an antigen that protect in experiment al mice.
3000 people vaccinated but only a minority of people developed skin-test positive results for coccidioidin.
Study Findings, Level & Quality
Only one human trial of a cocci vaccine done in the 1980’s.
This is a Level V study of C quality. However, it provided adequate evidence-based literature on the extensive histology and disease process of cocci.
Citation
McCurdy, S. A. et al. (2020). Emerging Infectious Diseases, 26(7), 1-6.
Purpose of Study
To determine occupational risk factors for cocci among adult Hispanic outdoor agricultural workers in California.
Design/Method
A case-control study. Data was collected from June 1, 2016 – August 31, 2018 from the Kern County Public Health Services Department (KCPHSD). A list was provided by
the KCPHSD of persons who had undergone serologic testing for cocci at the Kern County Public Health Laboratory.
Sample/Setting
Sample was obtained from the KCPHSD from June 1, 2016 – August 31, 2018. These patients were referred from Kern County Medical, a public healthcare facility where
local Hispanic agricultural workers seeked health care services. Age of sample was 18 years of age and older, who had > 1 positive serological test result (potential cases)
and a random sample of persons with all negative serologic test results (potential controls). Participants were of Hispanic o r Latino origins and had to have worked in outdoor
agriculture for > 1 month in the preceding year. Sample size was 203 participants (110 case-patients and 93 controls).
Major Variables
Specific crops: Root and bulb crops growing underground, near -ground crops, above-ground crops, cocci positive serological results, symptoms of infection (cough,
shortness of breath, fatigue and weakness) and the amount of dust exposure.
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Measurement of Major Variables
Questionnaire on demographic characteristic, health history, agricultural and work history, weekly hours, frequency of outdoor work, crop harvested, subjective dust
exposure, frequency of use of PPE (masks) in dusty conditions and soil wetting.
Data Analysis
Data was analyzed with Stata 15.1. For group comparisons, the researchers used the Fischer exact test from nonordinal categorical variables and the Kruskal-Wallis test for
continuous and ordinal categorical variables.
Study Findings, Level & Quality
More than three quarters of participants were born in Mexico. A significantly higher percentage of case -patients - 21% worked with root and bulb vegetables than the controls
– 9%. More case-patients (71%) than controls (56%) reported dust exposure. Case-patients were significantly more likely than controls to report symptoms associated with
cocci (weight loss, shortness of breath). The most frequent signs/symptoms among all participants were fatigue and cough. The results showed a 3-fold increase in the odds
of cocci among root and bulb vegetable crop workers. Level II design of A quality.
Citation
Nobel, J. et al. (2016). Emerging Infectious Diseases, 22(10), 1821-1823.
Purpose of Study
Analyze cocci-associated deaths in Arizona and California by race/ethnicity to the national statistics.
Design/Method
Case series analysis on Arizona and California from publicly available data from the CDC and Prevention National Center for H ealth Statistics (PNCHS) from 1990-2008 to
calculate national and state-specific mortality rates.
Sample/Setting
Review of cocci-related deaths from CDC and PNCHS. During 1990-2008, total cocci-related deaths 3,088 in the US. During the same period a total of 1,957 cocci-related
deaths were from Arizona and California.
Major Variables
Age, sex, race/ethnicity, US mortality, Arizona mortality and California mortality rates.
Measurement of Major Variables
The study used a generalized linear model with log-binomial construct to analyze the effect of sex, age and race. Categorized sex, age and race using univariate and
multivariate analyses.
Data Analysis
In both states, mortality rates were highest among men, and compared to non-Hispanic whites, all other racial groups had higher mortality rates.
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Study Findings, Level & Quality
The restricted analysis confirms that cocci-related deaths increase with age and are higher in males. African-Americans have the highest incidence. Endemic regions have
higher cocci-related deaths than the national average. This is a Level II study of A quality.
Citation
Tartof, S.Y. et al. (2018). Emerging Infectious Diseases, 24(4), 779-781.
Purpose of Study
Identify characteristics associated with testing positive for cocci among patients with CAP.
Design/Method
Cohort study using the Kaiser Permanente Southern California (KPSC) healthcare system to collect patient diagnoses.
Sample/Setting
KPSC patients diagnosed with CAP, the researchers wanted to know if CAP were tested for cocci. The cohort sample included 33,756 patients.
Major Variables
Variables tested: clinical knowledge, diagnostics and treatments given.
Measurement of major variables
Questionnaire on demographic characteristic, health history, agricultural and work history, w eekly hours, frequency of outdoor work, crop harvested, subjective dust
exposure, frequency of use of PPE (masks) in dusty conditions and soil wetting.
Data analysis
Data was analyzed with Stata 15.1. For group comparisons, the researchers used the Fischer exact test from nonordinal categorical variables and the Kruskal-Wallis test for
continuous and ordinal categorical variables.
Study findings/level/quality
A geographical map is illustrated in the article where Kern County had the highest incidence rate for testing positive for cocci than had Los
Angeles County patients. The study found a low testing rate in CAP with cocci infections, the researchers recommended additio nal VF
education for physicians and the community to improve overall detection for early treatment and reduced health care expenditure. This was
a Level IV study design of A quality.
Citation
Wilson, L. et al. (2019). International Journal of Environmental Research and Public Health, 16, 1-16.
Purpose of Study
This cost-of-illness study provided the cost burden of cocci to aid in health planning and funding as CI continue to surge in California. The researchers calculated the lifetime
direct and indirect costs of CIs.
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Design/Method
Case report design. Reviewed incidence cases and the natural history of the disease, the researchers then calculated the lifetime costs by identifying specific items of
healthcare use. The frequency of healthcare use was then multiplied by the proportion of cases utilizing the healthcare item. The data was obtained from literature, national
datasets, and expert interviews. The expert interviews were used to better understand the natural progression of valley fever and to help guide treatment algorithms. Guided
interviews were done with valley fever experts from endemic regions in California in a form of a questionnaire.
Sample/Setting
Study population was 2017 reported valley fever cases in California, n = 7466. The researchers estimated the expected lifetim e cost of CI for the study population based on
the natural history of valley fever and its published treatment guidelines.
Major Variables
Variables were major manifestations that patients experienced of a CI: 1) Uncomplicated pneumonia, 2) Diffuse and/or chronic pneumonia without dissemination, 3)
Disseminated disease, including meningitis, and 4) other physiological changes in chest (pulmonary nodules and cavities). Costs of healthcare utiliza tion in direct and indirect
costs related to a CI diagnosis.
Measurement of Major Variables
Total lifetime cost burden of all reported valley fever cases in 2017 (n = 7466). Calculated the direct and indirect costs of healthcare use in dollars.
Data Analysis
Direct costs included diagnosis and treatment, follow-up physician visits and treatment procedures, hospitalizations, medications and nursing home care. The researchers
used ICD-10 codes: B38.0, B38.4, B38.89 and B38.9 obtained from the California patient discharge dataset 2017.
Indirect costs included, lost days of work, short-and long-term disability and mortality costs. These estimates were taken from the Federal Reserve Economic Data. A multiple
one-way sensitivity analyses were also conducted to adjust for errors in reporting or misdiagnosis.
Study Findings, Level & Quality
The estimated total lifetime cost burden of all valley fever cases reported in 2017 in California (n = 7466) was just under $700 million (discounted), with $429 million in direct
costs and $271 million in indirect costs. Level IV of A quality.
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Appendix B:
Conceptual Model of Nursing and Population Health
(Fawcett & Ellenbecker, 2015)

Upstream
Factors

Nursing
Activities

Population
Factors

Population
Health
outcomes

Healthcare
System
Factors

Reference: Fawcett & Ellenbecker, 2015

Upstream factors: socioeconomic and physical environmental.
Population factors: genetics, behavior, physiological issues, resilience, and health state within a
defined geographical area.
Health care system factors: providers, organizations and institutions, payers and policies.
Nursing activities: health promotion and wellness, restoration, maintenance, and disease
prevention.
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Appendix C: Gap Analysis

Current State
•High-risk populations
who work in soil
disturbing
occupations and
individuals who live
in high dust areas are
exposed to the fungal
spore coccidiodes.

•No current algorithm
to diagnose and treat
coccidioidomycosis
infections to exposed
groups in primary
care practices.

Identified Gaps

Future State

•In current clinical
practices, especially in
the primary care setting,
the providers are
uninformed on how to
identify and treat highrisk groups who present
with clinical symptoms
of cocci.

•Educate PCPs and allied
healthcare
profressionals on the
pathogenesis of cocci,
recognize the symptoms
of a CI, assess individual
risk factors, prevention ,
diagnose and treat
infected individuals
effectivley and promptly.

•At the present time,
patient who present with
an acute respiatrory
infection are given
multiple rounds of
inappropriate antibiotics
due to a misdiagnosis of
a CI.
•PCPs are not trained to
recognize risk factors to
diagnose and treat
appropriately for a CI in
vulnerable individuals
who are exposed to dust.

•Reduce mobidity and
disemmation of disease.
•Reduce the illness
trajectory.
•Reduce healthcare
expenditure.

•Long-term goal: policy
change through state
legislation on medical
practices for PCPs in the
treatment of VF.
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Appendix D: Learning Objectives

EDUCATION FOR PRIMARY CARE PROVIDERS ON VALLEY FEVER
PRESENTED BY MICHELLE BERGEN FNP-BC: USF DNP STUDENT
BACKGROUND
The San Joaquin Valley is a semiarid region known to be endemic for coccidioidomycosis
infections (Valley Fever) in high-risk groups. The fungus spore coccidioides resides in semi-arid
soils, and when the soil is disturbed through excavation, construction, tilling or any other
agricultural activities, dust clouds are aerosolized and people in close proximity can inhale it.
Valley Fever is a respiratory infection that can disseminate to other parts of the body causing
organ failure and complicated disease.
PURPOSE
This education provides primary care providers the risks, symptoms, diagnostic testing and
treatments needed to detect and treat Valley Fever early in the disease continuum.
OBJECTIVES
Define coccidioidomycosis and its pathogenesis
Review the symptoms of a coccidioidomycosis infection
Determine how to assess individual risk factors and identify vulnerable groups.
Examine the precautions that are needed to help prevent a coccidioidomycosis infection.
Describe and execute an algorithm on when and how to treat clinical symptoms of
coccidioidomycosis.
EDUCATION SESSION
Sessions will be conducted virtually at the Adventist Health Central Valley Network Clinics
Education will be given to the providers at the Central Valley Clinics and any other nursing staff
members who are interested in learning about Valley Fever.
Sessions date and time was determined by Market Medical Director for August 26, 2020 at 12:00
PM – 1:00 PM PST.
The educator will be using a slide presentation and distributing a management algorithm for
uncomplicated Valley Fever, and Valley Fever pamphlets in both English and Spanish for the
patients at Adventist Health.
A follow-up visit was not necessary and additional education sessions on VF were offered if
needed.
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Appendix E: Gantt chart
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Appendix F: Work Breakdown Structure
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Appendix G: Communication Matrix

Methods of
Information
DNP Project Status

Audience
DNP Chair: Dr. Juli
Maxworthy

Time
Weekly

communication
Zoom and email

Primary Stakeholders
at Adventist Health,
Hanford, CA
DNP student

Monthly

Skype
Email
Telephone
Virtual meeting

DNP Chair: Dr. Juli
Maxworthy
Primary Stakeholders
at Adventist Health,
Hanford, CA
DNP student
Barriers/Issues/Resoluti DNP Chair: Dr. Juli
ons with the DNP
Maxworthy
Project
Primary Stakeholders
at Adventist Health,
Hanford, CA
DNP student

Weekly

Zoom

Changes/Revisions of
the DNP Project

Milestones to DNP
Project

DNP Chair: Dr. Juli
Maxworthy
Primary Stakeholders
at Adventist Health,
Hanford, CA
DNP student

Continuous

Weekly

Email
Virtual Meeting
Telephone
Zoom and email

Continuous

Skype
Email
Telephone
Virtual meeting

Weekly

Zoom and email

Skype
Email
Telephone
Virtual meeting
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Appendix H: SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

Addresses the
Healthy People
2020 health
indicator by
improving the
environment of
communities who
are exposed to air
borne diseases with
a secondary
prevention measure
in place.

The population’s
language and
knowledge barriers,
affordability of and
access to
healthcare services
can result in
inaccurate or
diminished cocci
surveillance.

Opportunities can
come about from the
stakeholders
themselves, the CDC
and CDPH are well
funded and are under
legislative control.
These organizations
could possibly make
this educational
program mandatory for
PCPs in the Central
Valley where the
prevalence is high.

The potential threat that could
have occurred but did not
happen, if Adventist Health
abandoned the VF project due
to time constraints, disinterest
about the disease or if they felt
that there were more concerning
health issues than VF that
needed to be addressed.

Anticipated lack of
patient compliance
due to the lengthy
treatment regime.

Initiate evidencedbased guidelines to
test, diagnose and
treat VF earlier in
the disease process, Low % of responses
resulting in improved on the surveys led
to a low statistical
health outcomes.
power.
By changing the
communities’
physical
environment through
the use of protective
factors, it will reduce
dust exposure and
reduce the chance
of a CI to the lungs.

CME credit for 1.o hour
was awarded to all
participants.
Valley Fever is
publicized as a
national concern,
making the medical
profession and the
public more aware of
the disease.
Epidemiology and
immunology are
involved to invest in
research to and come
up with better and
more efficient
diagnostic tests and a
possible vaccine.

Delay in the implementation of
the DNP project due to the
current crisis of COVID-19 and
social distancing. This occurred
after the DNP project was
established.
Project was delayed by one
month due to approval for CME
credit from the AAFP.
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Appendix I: Project’s Budget
Adventist Health, Selma Clinic
1141 Rose Avenue, Selma, CA 93662

Providers (NPs, Pas, allied staff), including the marketing director, Family

40

Practice M.D.
Office Administrator:

1

CDPH Population Health Vice President:

1

Executive Assistant Administrator:

1

Project Manager (DNP Student) $62.50/ hour x 10 hours a week for 24

$15,000.00

weeks
Printing of seven training manuals and algorithm reference sheets and

$140.00

patient education pamphlets at a cost of
Mileage calculated for two clinic visits at 0.58 cents/ mile x 92 miles round

$53.36

trip of
Cost of accreditation for CME credit for 1.0 unit
Gas will be approximately
Total Project Budget:

$295.00
$20.00
$15,508.36

Note: salaries for the providers, allied healthcare professionals and administrative staff are not calculated
into the budget because the education session was done during the clinic’s lunch hour period.
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Appendix J: Pre/Post-Knowledge Survey
Please complete these 10 knowledge questions, thank you.
1. The Central valley is considered highly endemic for coccidioidomycosis
A) True
B) False

2. In the environment the coccioides species is a:
A) Bacteria
B) Virus
C) Fungus
D) Protozoa
E) Parasite

3. What is the mode of transmission of coccidioidomycosis?
A) Contact (direct or indirect)
B) Droplet
C) Airborne
D) Common vehicle

4. What are the major clinical symptoms of Valley Fever?
A) Fatigue, fevers, nocturnal diaphoresis, weight loss, cough, dyspnea
B) Chills, fever, cough, sore throat, nausea/vomiting, shortness of breath
C) Diffuse generalized rash, itchy skin, nocturnal diaphoresis, painless swelling of
lymph nodes in your neck, armpits and groin
D) No symptoms
5. Risk factors for Valley Fever:
A) People who work and live in high dust areas
B) African-America, Filipinos, Native Americans, Hispanics, Asians
C) Diabetics
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D) Pregnant women
E) Immunocompromised
F) All of the above

6. Testing patients with a possible acute coccidioidomycosis infection what initial
diagnostic tests would you order? (you can choose more than one answer)
A) Skin test with the antigen SPHERUSOL
B) CBC, ESR, C-reactive protein
C) Cocci serology Enzyme-linked immunoassays (EIA) with IgM, IgG
D) Immunodiffusion (ID) and Complement Fixation (CF)
E) Chest X-ray
F) Mycology cultures
G) All of the above
7. A negative serologic test for coccidioidomycosis should exclude the patient as having a
coccidioidal infection after the first serology testing.
A) True
B) False

8. Should patients who present with mild symptoms or are asymptomatic with a positive
cocci serology, should you initiate therapy?
A)

Yes

B)

No

9. Patients who are newly diagnosed with Valley Fever, and are symptomatic, what is the
primary treatment?
A)

Amphotericin B

B)

Voriconazole

C)

Posaconazole

D)

Ketoconazole

E)

Fluconazole

VALLEY FEVER: EDUCATING PROVIDERS

10.

How long should a patient diagnosed with Valley Fever be on surveillance?
A)

3 months

B)

6 months

C)

12 months

D)

24 months

73

VALLEY FEVER: EDUCATING PROVIDERS
Appendix K: Activity Evaluation

Thank you for participating in the Valley Fever educational activity, please
complete the survey.
1. Presenter knowledge and effectiveness of the content presented:
• Strongly agree
• Agree
• No opinion
• Disagree
• Strongly disagree
2. The virtual format was appropriate for the subject matter and I was able to access the
pre/post educational surveys without difficulty:
• Strongly agree
• Agree
• No opinion
• Disagree
• Strongly disagree
3. This educational activity will assist in the improvement of my: (check all that apply)
• Competence
• Performance
• Patient outcomes
4. I plan
•
•
•
•

to make the following changes to my practice: (check all that apply)
Modify treatment plans
Change my screening/prevention practice
Incorporate different diagnostics strategies into patient evaluation
None, the activity validated current practice

5. What is your level of commitment to making the changes learned from this activity?
• Very committed
• Somewhat committed
• Not very committed
• Do not expect to change practice strategies
6. What are the barriers you face in your current practice setting that may impact patient
outcomes: (check all that apply).
• Lack of evidenced-based guidelines
• Lack of applicability of guidelines to my current practice/patients
• Lack of time
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•
•
•
•
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Organizational/Institutional
Patient adherence/compliance
Treatment related adverse effects
Patient’s insurance

7. This this activity achieve the learning objectives:
• Strongly agree
• Agree
• No opinion
• Disagree
• Strongly disagree
8. The material was organized clearly for learning to occur:
• Strongly Agree
• Agree
• No opinion
• Disagree
• Strongly disagree
9. The content learned from this activity will impact my practice and/or the healthcare team:
• Strongly Agree
• Agree
• No opinion
• Disagree
• Strongly Agree
10. Does this activity promote improvement in healthcare and/or patient outcomes?
• Yes
• Maybe
• No
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Appendix L: Proposed CQI and Data Collection Tools

Data

Variable name

Brief description

source

Education

Pre-educational assessment
on knowledge of VF

Survey

VF screening,
testing, diagnosing
and treating
clinical symptoms
of VF

A 45-minute educational
session conducted virtually at
the providers’ workplace

Tool

Providers selfassessment on
their ability to
accurately identify
and diagnose
cocci

Educational satisfaction
surveys distributed to the
participants on their newly
attained knowledge about VF
and if they would change their
practice interventions

Survey

Tools/Analyzing data

Measurement
type

Time frame

Pre-educational 10-item
questionnaire using a 3-7-point
Likert Scale

Medians and
quartiles of counts
and percentages,
using Qualtrics

Six weeks

PowerPoint slide presentation,
Cocci algorithm sheet and a VF
training manual will be the tools
for the education. The VF
training manuals will be kept by
the providers for future
referencing
10-item questionnaire using a
Likert Scale with an ordinal scale
response set from 0 (not at all) to
5 (extremely satisfied).

Post-educational
10-item
questionnaire
using a 3-7-point
Likert Scale, using
Qualtrics

One educational
session
approximately 45
minutes in length
and 15 minutes
for Q&A

Medians and
quartiles of counts
and percentages,
using Qualtrics

Two weeks
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Appendix M: Map of California Farming
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Appendix N: Budget Table
Valley Fever Education for Primary Care Providers
Fiscal Year July 1 – June 30, 2020

Direct costs
# of

for uncom

Direct costs

Indirect

Cost of the

# of

PCPs

cocci with

for disease

costs

educational

FY 2020

FY 2021

VF

at

pneu

Spread

pp/year

session for

ROI

Cases

AH

pp/year

pp/year

For VF

1 hour

$45.2 M

2.1 B

$74.5 M

$0

2,053

40

Total ROI over

Total ROI for

FY 2022

3 years for

indirect cost burden

ROI

ROI

both direct &

pp/year over 3 years

at 8.3%

at 8.3%

at 8.3%

indirect costs

at 25%

$148.5 M

$178.2 M

$178.2 M

$534.6 M

$9,038.19
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Figure 1: Appendix O: Pre and Post knowledge Comparison
Table

QUESTIONS 1 - 10

CHOICE OF ANSWERS

RESPONSES

RESPONSES

ANSWER(S)

AVAILABLE

(PRE) % N =13

(POST) % N = 8
True

100.00

100.00

False 0.00

False 0.00

Bacteria

7.69

0.00

Virus

7.69

0.00

Fungus

84.62

100.00

Protozoa

0.00

0.00

Parasite

0.00

0.00

Contact

23.08

12.50

Droplet

0.00

0.00

Airborne

76.92

87.50

Parasite

0.00

0.00

10.58

Diffuse generalized rash, itchy skin,

84.62

100.00

15.38

nocturnal

nocturnal diaphoresis, painless

7.69

0.00

7.69

diaphoresis,

swelling of lymph nodes in your
0.00

0.00

0.00

7.69

0.00

7.69

African-Americans, Filipinos, Native

15.38

0.00

15.38

Americans, His panics, Asians

0.00

0.00

0.00

Diabetics

0.00

0.00

0.00

Pregnant women

0.00

0.00

0.00

Immune-compromised

0.00

0.00

0.00

82.62

100.00

17.38

0.00

0.00

0.00

15.63

25.00

9.37

True

True
False

IN THE ENVIRONMENT THE
Fungus

WHAT IS THE MODE OF
TRANSMISSION OF COCCI?

DIFFERENCE %

True

ENDEMIC FOR COCCI

COCCIDIOIDES SPORE IS A:

CORRECT

CORRECT

THE CENTRAL VALLEY IS
CONSIDERED HIGHLY

CORRECT

Airborne

0.00

15.38

Fatigue, fevers, nocturnal diaphoresis,
weight loss, cough, dyspnea
Chills, fever, cough, sore throat, N/V,
SOB
Fatigue, fevers,
WHAT ARE THE MAJOR
CLINICAL SYMPTOMS OF

weight loss,

VF?

cough, dyspnea

neck, armpits and groin
No symptoms
People who work and live in high dust
areas

RISK FACTORS FOR VF

All of the above

All of the above

TESTING PATIENTS WITH A

CBC, ESR, C-

Skin test with the antigen Spherusol

POSSIBLE ACUTE COCCI

reactive protein,

CBC, ESR, C-reactive protein
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INFECTION, WHAT INITIAL

cocci serology,

Cocci serology EIA with IGM, IgG

31.25

31.25

0.00

DIAGNOSTIC TESTS

EIA with IgM,

ID, CF

12.50

0.00

-12.50

WOULD YOU ORDER?

IgG, ID, CF,

Chest X-Ray

25.00

31.25

6.25

Chest X-ray,

Mycology cultures

6.25

0.00

-6.25

All of the above

9.30

12.50

-3.20

Mycology
cultures
A NEGATIVE SEROLOGIC
TEST FOR COCCI SHOULD
EXCLUDE THE PATIENT AS
HAVING A COCCI

True 16.67

INFECTION AFTER THE

True

False

0.00

False

83.33

100.00

Yes

53.85

25.00

No

46.15

75.00

PATIENTS WHO ARE NEWLY

Amphotericin

15.38

12.50

DIAGNOSED WITH VF AND

Voriconazole

7.69

0.00

ARE SYMPTOMATIC, WHAT

Posaconazole

0.00

0.00

FIRST SEROLOGY TEST.

False

16.67

PATIENTS WHO PRESENT
WITH MILD SYMPTOMS OR
WHO ARE ASYMPTOMATIC
WITH A POSITIVE COCCI
RESULT, SHOULD YOU
INITIATE TREATMENT?

No

IS THE PRIMARY DRUG
TREATMENT?

Fluconazole

HOW LONG SHOULD A
PATIENT DIAGNOSED WITH
VF BE ON SURVEILLANCE?

12 months

28.85

Ketoconazole

0.00

0.00

Fluconazole

76.92

87.50

10.58

3 months

0.00

0.00

0.00

6 months

30.77

0.00

30.77

12 months

61.54

75.00

13.46

24 months

7.69

25.00

17.31
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Appendix P: Pre educational Survey Results
Figure 2: Pre educational survey results: Question #1.

Figure 3: Pre educational survey results: Question #2.
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Figure 4: Pre educational survey results: Question #3.

Figure 5: Pre educational survey results: Question #4.

Figure 6: Pre educational survey results: Question #5.
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Figure 7: Pre educational survey results: Question #6.
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Figure 8: Pre educational survey results: Question #7.

Figure 9: Pre educational survey results: Question #8.
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Figure 10: Pre educational survey results: Question #9.

Figure 11: Pre educational survey results: Question #10
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Appendix Q: Post educational Survey Results
Figure 12. Post educational survey results: Question #1.

Figure 13. Post educational survey results: Question #2.
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Figure 14. Post educational survey results: Question #3.

Figure 15. Post educational survey results: Question #4.
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Figure 16. Post educational survey results: Question #5.

Figure 17. Post educational survey results: Question #6.
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Figure 18. Post educational survey results: Question #7.

Figure 19. Post educational survey results: Question #8.
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Figure 20. Post educational survey results: Question #9.

Figure 21. Post educational survey results: Question #10.
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Appendix R: Post Activity Survey Results
Figure 22. Activity Evaluation results: Question #1.

Figure 23. Activity Evaluation results: Question #2.
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Figure 24. Activity Evaluation results: Question #3.

Figure 25. Activity Evaluation results: Question #4.
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Figure 26. Activity Evaluation results: Question #5.

Figure 27. Activity Evaluation results: Question #6.
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Figure 28. Activity Evaluation results: Question #7.

Figure 29. Activity Evaluation results: Question #8.
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Figure 30. Activity Evaluation results: Question #9.

Figure 31. Activity Evaluation results: Question #10.
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Table 1
Satisfaction Table of Summarized Results: Presenter Knowledge of Content and Mode of
Delivery
Neither
Strongly
Question

Somewhat

agree nor

Somewhat

Strongly

agree

disagree

disagree

Disagree

disagree

agree

Agree

75%

25%

0%

0%

0%

0%

0%

50%

12.5%

0%

12.5%

0%

12.5%

12.5%

62.5%

25%

12.5%

0%

0%

0%

0%

75%

12.5%

0%

0%

12.5%

0%

0%

50%

50%

0%

0%

0%

0%

0%

Presenter knowledge and
effectiveness of the content
presented.
The virtual format was
appropriate for the subject
matter and I was able to
access the pre/post
educational surveys without
difficulty.
This activity achieved the
learning objectives.
The material was organized
clearly for learning to occur.
The content learned from this
activity will impact my
practice and/or the
healthcare team.

97

VALLEY FEVER: EDUCATING PROVIDERS
Table 2
Level of Improvement in Practice
Question

Competence

Performance

Patient outcomes

40%

30%

30%

This educational activity will assist me in the improvement of
my practice in:

Table 3
Strategies of Treatment
Modify

Change my

Incorporate different

None, this activity

treatment

screening/

diagnostic strategies into

validated the

plans

prevention practice

the patient evaluation

current practice

20%

30%

50%

0%

Question
I plan to make the following
changes to my practice

Table 4
Level of Commitment to New Guidelines for VF
I do not expect to

Question

Somewhat

Not very

change practice

Very committed

committed

committed

strategies

100%

0%

0%

0%

What is your level of commitment to making
the changes learned from this activity?
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Table 5
Improvement of Patient Outcomes
Question
Does this activity promote improvement in healthcare and/or patient outcomes?

Yes

No

Maybe

100%

0%

0%

Table 6
Current Barriers in Clinical Practice that may impact Patient Outcomes
Lack of
applicability
Lack of

of guidelines to

Treatment

evidenced-

my current

based

practice/

Lack of

guidelines

patients

0%

7.69%

Patient

Related

Organizational/

Adherence or

adverse

Patient

time

Institutional

compliance

effects

insurance

15.38%

7.69%

38.46%

0%

30.77%
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Appendix S: Valley Fever Algorithm

Recognition, Evaluation and Management of
Coccidioidomycosis (Valley Fever )

Just Remember C-O-C-C-I
RECOGNITION

C

Consider the diagnosis
Respiratory: Previous visit, needs X-ray or antibacterial Rx?
Musc/Skel: More than one week, associated with fever or
fatigue.
Rashes: E. nodosum or E. multiforme
Clinician reviews chief
complaint(s) and medical
history, examines patient,
and documents findings
( HPI, ROS, PE)

Syndrome:
respiratory?
musculoskel?
rashes?

Yes

Go to:
Order
the
right
tests

Yes
Add
Valley Fever
to the
Differential

Endemic
Exposure?
residence
or recent
travel

No

Valley Fever
Process Completed

No
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RECOGNITION continued

O

Order the right tests
EIA screen for coccidioidal antibodies with reflex to
immunodiffusion and quantitative CF.
Order EIA
screen for
coccidioidal
antibodies

No

Test
Negative

Yes
Illness resolved in
3 weeks

Valley Fever
Process Completed

Go to:
&
Check for risks and
complications

Test
Positive

EVALUATION

C
C

Check for Risk Factors
Immunosuppression (HIV, organ recipient, Rheum/GI/Derm
response modifier Rx, renal failure)
Diabetes, major cardiac or pulmonary comorbidities, pregnancy

Check for complications evident by physical
exam or imaging
Focal ulceration or skin/soft tissue inflammation.
Asymmetric skeletal pain, joint effusions.
Progressive or unusual headache.

No
Risk factors
present?

No
Complications
present?
Yes

Yes

Go to:
Management,
Uncomplicated infect.
Complicated VF:
Refer to Specialist
(ID or Pulmonary)
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MANAGEMENT

Initiate Management, Uncomplicated VF

I
Diagnosis

f/u Visit #1

f/u Visit #2

f/u Visit #3

Approximate Timeline for Management (6-12 months from diagnosis)

Serologic newly
diagnosed
Valley Fever

Risk factors
Complications
?

No

Schedule
follow-up visit #1
2-5 weeks

Yes
Refer to Specialist
(ID or Pulmonary)
Yes
Follow-up visit #1
Interval hx
Review of Syst
Phys. Exam

New
Complication
?

No Repeat PA and lat.
Chest X-ray
(if previous was
abnormal)

Schedule
follow-up visit #2
2-3 months

Follow-up visit #2
Interval hx
Review of Syst
Phys. Exam

New
Complication
?

No

Repeat cocci CF
antibody test, ESR
and/or C- reactive
protein

Schedule
follow-up visit #3
3-8 months

Yes
Refer to Specialist
(ID or Pulmonary)
Yes
Follow-up visit #3
Interval hx
Review of Syst
Phys. Exam

New
Complication
?

No Repeat PA and lat.
Chest X-ray
(check for residual
nodule)

Valley Fever an
inactive problem
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Appendix T: AAFP CME Certificate

CERTIFICATE OF PARTICIPATION
This certifies that:

______________________________________________________
(Name of Physician Participant)

has participated in the educational activity entitled:

Valley Fever Education for Primary Care Providers and Allied Healthcare Professionals
(Title of CME Activity)

provided by: Michelle Bergen MSN, FNP-BC, CONC
(Name of CME Provider)

08-26-2020
(Date of Activity)

Fresno County, California
(City/State of Activity)

and is awarded up to 1.0 credits.

This virtual education series, Valley Fever for Primary Care Providers and Allied Healthcare Professionals with a beginning date of
August 26, 2020 has been reviewed and is acceptable for up to 1.0 credit(s) by the American Academy of Family Physicians.
Physicians should only claim the credit commensurate with the extent of their participation in the activity.

I participated in 1.0 credits of this CME activity.
Signature of CME Activity Director

____________________________ 08-26-2020
Physician Participant’s Signature

Date

08-26-2020

Date
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Appendix U: Patient Information Pamphlet (English)

Contact your local health department
or visit the following websites for
more information on Valley Fever:

How can I reduce the risk of Valley
Fever?
The best way to reduce the risk is to
avoid breathing in dirt or dust in places
where Valley Fever is common.

http://www.cdph.ca.gov/Programs/CID/
DCDC/Pages/Coccidioidomycosis.aspx
http://www.cdc.gov/fungal/diseases/cocc
idioidomycosis/index.html

For proper fitting of an N95 mask:
http://youtu.be/0d_RaKdqeck

Below are some common sense
recommendations that may
help:

What you need
to know about
Valley Fever in
California

When it is windy and the air is
dusty, especially during dust storms:
• Stay inside and keep windows and

doors closed.

• While driving, keep car windows

shut and use “recirculating” air
conditioning if available.
• If you must be outdoors, consider
wearing an N95 mask or respirator
(available at drug and hardware
stores).
When working or playing in areas with
open dirt:
• Wet down soil before disturbing it to

reduce dust.
• Consider wearing an N95 mask.
July 2017

State of California
California Department of Public Health
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Appendix V: Patient Information Pamphlet (Spanish)

Para más información sobre la Fiebre del
Valle, contacte a su departamento de salud
local o visite los siguientes sitios Web (en
inglés):

¿Cómo puedo reducir el riesgo de
contraer la Fiebre del Valle?
La mejor manera de reducir el riesgo es
evitar aspirar suciedad o polvo en lugares
donde la Fiebre del Valle sea común.
A continuación se indican algunas
recomendaciones de sentido común
que pueden ayudar:

https://www.cdph.ca.gov/Programs/CID/
DCDC/Pages/Coccidioidomycosis.aspx
http://www.cdc.gov/fungal/diseases/coccidio
idomycosis/index.html
Para el ajuste apropiado de una máscara o
respirador N95:
http://youtu.be/0d_RaKdqeck

Lo que
necesita saber
sobre la Fiebre
del Valle en
California

Cuando hace viento afuera y
hay polvo en el aire, sobre todo durante
tormentas de polvo:
Quédese adentro, y mantenga las
puertas y ventanas cerradas.
Mientras vaya manejando, mantenga
cerradas las ventanas del auto y
utilice la función de “recirculación” del
aire acondicionado si está disponible.
Si tiene que estar al aire libre cuando
hay polvo en el aire, considere
ponerse una máscara o respirador
N95 (disponible en farmacias y
ferreterías).
Cuando trabaje o juegue en áreas
abiertas con suciedad o polvo:
Humedezca la tierra antes de alterarla
para reducir el polvo.
Considere ponerse una máscara o
respirador N95.

julio de 2017

Estado de California
Departamento de Salud Pública de California
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Appendix W: Education Flyer Valley Fever
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Appendix X: Statement of Non-Research Determination

Student Name: Michelle Bergen
Title of Project:
Valley Fever: Educating Primary Care Providers and Allied Healthcare professionals Educational
Program
Brief Description of Project:
According to the CDC (2018), the Central Valley has a high incidence and prevalence of
coccidioidomycosis (cocci) infections in high-risk populations who are of African American,
Filipino, Native American, and Hispanic origins, who work in soil disturbing occupations such as
agriculture, construction, mining and wildfire clearing. In addition to the occupational exposures,
surrounding communities are also affected. The cocci fungus is an aerolized spore inhaled by
individuals who work and live in close proximity to dirt and dust. In current clinical practices,
Valley Fever is often diagnosed as a common respiratory infection or community-acquired
pneumonia by the primary care providers (PCP).
A) Aim Statement:
By August 2020, the project’s aim is to develop, implement and evaluate a Valley Fever
educational program for healthcare providers. This educational program will help healthcare
providers to correctly identify and treat vulnerable populations ages 18 and over with clinical
symptoms of Valley Fever.
B) Description of Intervention:
At the present time there are no mandatory cocci screening and testing programs for healthcare
providers for individuals working in soil disturbing occupations or communities that live in
high dust areas, who may present with clinical cocci. The intervention is to develop and
implement a Valley Fever educational program, primarily for healthcare providers.
C) How will this intervention change practice?
The project’s goal will be to increase the healthcare providers’ knowledge on the prevalence of
Valley Fever infections, its disease pathology and increase the percentage of early screening in
high-risk groups, resulting in early diagnosis and appropriate treatment.
D) Outcome measurements:
Outcome measurements will be measured of the healthcare providers’ knowledge by statistical
analysis on Valley Fever from pre-educational survey results compared to post-educational
survey results. Educating the providers and allied health professionals on Valley Fever will
increase their knowledge by about 90% on the correct diagnosis and treatment, resulting in
sooner recovery of the affected groups.
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• Increase knowledge of signs, symptoms and treatment of Valley Fever by 25% of
participants in the educational session.
• Majority of feedback (at least 4/5 on Likert Scale) of participants of the educational
activity.
• Satisfaction of participants (4/5 on Likert Scale) on the usability of the toolkit.

To qualify as an Evidence-based Change in Practice Project, rather than a Research Project, the
criteria outlined in federal guidelines will be used:
(http://answers.hhs.gov/ohrp/categories/1569)

X This project meets the guidelines for an Evidence-based Change in Practice Project as
outlined in the Project Checklist (attached). Student may proceed with implementation.

☐ This project involves research with human subjects and must be submitted for IRB approval
before project activity can commence.
Comments:
EVIDENCE-BASED CHANGE OF PRACTICE PROJECT CHECKLIST *
Instructions: Answer YES or NO to each of the following statements:

Yes

Project Title: Improvement in Environmental Health on Valley Fever Education and
Awareness to Primary Care Providers in the Central Valley.

X

The aim of the project is to improve the process or delivery of care with established/ accepted
standards, or to implement evidence-based change. There is no intention of using the data for
research purposes.

X

The specific aim is to improve performance on a specific service or program and is a part of
usual care. ALL participants will receive standard of care.

X

The project is NOT designed to follow a research design, e.g., hypothesis testing or group
comparison, randomization, control groups, prospective comparison groups, cross-sectional,
case control). The project does NOT follow a protocol that overrides clinical decisionmaking.

X

The project involves implementation of established and tested quality standards and/or
systematic monitoring, assessment or evaluation of the organization to ensure that existing
quality standards are being met. The project does NOT develop paradigms or untested
methods or new untested standards.

X

The project involves implementation of care practices and interventions that are consensusbased or evidence-based. The project does NOT seek to test an intervention that is beyond
current science and experience.

X

No
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The project is conducted by staff where the project will take place and involves staff who are
working at an agency that has an agreement with USF SONHP.

X

The project has NO funding from federal agencies or research-focused organizations and is
not receiving funding for implementation research.

X

The agency or clinical practice unit agrees that this is a project that will be implemented to
improve the process or delivery of care, i.e., not a personal research project that is dependent
upon the voluntary participation of colleagues, students and/ or patients.

X

If there is an intent to, or possibility of publishing your work, you and supervising faculty and
the agency oversight committee are comfortable with the following statement in your methods
section: “This project was undertaken as an Evidence-based change of practice project at X
hospital or agency and as such was not formally supervised by the Institutional Review
Board.”

X

ANSWER KEY: If the answer to ALL of these items is yes, the project can be considered an
Evidence-based activity that does NOT meet the definition of research. IRB review is not
required. Keep a copy of this checklist in your files. If the answer to ANY of these questions
is NO, you must submit for IRB approval.
*Adapted with permission of Elizabeth L. Hohmann, MD, Director and Chair, Partners Human
Research Committee, Partners Health System, Boston, MA.
STUDENT NAME (Please print): Michelle Bergen
________________________________________________________________________
Signature of Student: Michelle Bergen
DATE: 09/03/2019

SUPERVISING FACULTY MEMBER (CHAIR) NAME Dr. Juli Maxworthy, DNP, MSN,
MBA, RN, CNL, CPHQ, CPPS, CHSE, FNAP, FSSH
______________________________________________________________________
Signature of Supervising Faculty Member (Chair): _________________ DATE: 12/2020
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Appendix Y: Letter of Support from Adventist Health

Valley Fever Educational Program for Primary Care Providers

May 11, 2020
To whom it may concern:
This letter of support is being written at the request of Michelle Bergen, DNP student from the
University of San Francisco, CA, to support her DNP project implementation at Adventist Health
Network. On behalf of our providers at the Adventist Health Community Network, I support
Michelle Bergen in her DNP project to implement and grow a potential need in education for
Valley Fever for our providers, under the approval and coordination of Dr. Raul Ayala, MD from
June 2020 through September 2020. Please feel free to contact me with any questions or
concerns regarding this statement of support.

Respectfully,

Dr. Raul Ayala, MD
Market Medical Director, Adventist Health – Central Valley Network

VALLEY FEVER
Appendix Z: PowerPoint Education Slides
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